Submitted URL: http://link.email.clinicaladvisor.com/a/1323/click/68670/2332181/7c3a4d985e81847c86d9bf2fe834451d4a19f32f/f2e2cf5d21125c5eff6ae819bb99...
Effective URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-...
Submission: On September 20 via api from US

Summary

This website contacted 47 IPs in 7 countries across 36 domains to perform 216 HTTP transactions. The main IP is 54.210.29.109, located in Ashburn, United States and belongs to AMAZON-AES - Amazon.com, Inc., US. The main domain is www.clinicaladvisor.com.
TLS certificate: Issued by RapidSSL RSA CA 2018 on February 7th 2019. Valid for: a year.
This is the only time www.clinicaladvisor.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
1 2 35.238.92.4 15169 (GOOGLE)
23 54.210.29.109 14618 (AMAZON-AES)
23 94.31.29.64 33438 (HIGHWINDS2)
3 2a00:1450:400... 15169 (GOOGLE)
1 93.184.220.113 15133 (EDGECAST)
6 2a00:1450:400... 15169 (GOOGLE)
4 52.216.177.205 16509 (AMAZON-02)
1 2a00:1450:400... 15169 (GOOGLE)
1 2600:9000:20b... 16509 (AMAZON-02)
1 13.35.253.58 16509 (AMAZON-02)
2 2a00:1450:400... 15169 (GOOGLE)
1 8 216.58.206.2 15169 (GOOGLE)
1 2606:4700::68... 13335 (CLOUDFLAR...)
3 7 2a00:1450:400... 15169 (GOOGLE)
1 4 2.19.43.224 20940 (AKAMAI-ASN1)
5 2a00:1450:400... 15169 (GOOGLE)
3 2a03:2880:f02... 32934 (FACEBOOK)
2 2 54.156.255.160 14618 (AMAZON-AES)
2 2 35.227.248.159 15169 (GOOGLE)
1 3.211.28.224 14618 (AMAZON-AES)
1 143.204.207.113 16509 (AMAZON-02)
1 151.101.12.134 54113 (FASTLY)
67 2606:4700:20:... 13335 (CLOUDFLAR...)
1 35.174.96.0 14618 (AMAZON-AES)
4 52.1.219.33 14618 (AMAZON-AES)
2 9 34.252.62.73 16509 (AMAZON-02)
3 3 2a00:1450:400... 15169 (GOOGLE)
3 3 2a00:1450:400... 15169 (GOOGLE)
3 2a00:1450:400... 15169 (GOOGLE)
3 2a03:2880:f12... 32934 (FACEBOOK)
1 34.233.109.111 14618 (AMAZON-AES)
1 1 104.111.241.32 16625 (AKAMAI-AS)
2 2 35.190.72.21 15169 (GOOGLE)
2 2 2.18.233.201 16625 (AKAMAI-AS)
2 2 34.252.7.165 16509 (AMAZON-02)
2 3 18.195.52.121 16509 (AMAZON-02)
2 35.227.192.113 15169 (GOOGLE)
5 35.172.78.117 14618 (AMAZON-AES)
7 2a00:1450:400... 15169 (GOOGLE)
1 143.204.214.25 16509 (AMAZON-02)
1 3.94.35.144 14618 (AMAZON-AES)
1 13.35.253.32 16509 (AMAZON-02)
2 143.204.214.39 16509 (AMAZON-02)
1 13.35.253.49 16509 (AMAZON-02)
3 2600:9000:205... 16509 (AMAZON-02)
3 2600:1f14:e96... 16509 (AMAZON-02)
1 3 2600:1f14:e96... 16509 (AMAZON-02)
1 3 2600:1f14:e96... 16509 (AMAZON-02)
1 34.223.224.174 16509 (AMAZON-02)
1 54.218.77.7 16509 (AMAZON-02)
1 2 34.250.208.218 16509 (AMAZON-02)
1 54.246.153.43 16509 (AMAZON-02)
1 3 2600:1f14:e96... 16509 (AMAZON-02)
1 54.191.43.35 16509 (AMAZON-02)
216 47
Apex Domain
Subdomains
Transfer
69 lytics.io
c.lytics.io
api.lytics.io
90 KB
26 clinicaladvisor.com
link.email.clinicaladvisor.com
www.clinicaladvisor.com
media.clinicaladvisor.com
8 MB
23 netdna-ssl.com
owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com
272 KB
15 b2c.com
api.b2c.com
api-34-223-224-174.b2c.com
api-54-218-77-7.b2c.com
api-54-191-43-35.b2c.com
20 KB
11 doubleclick.net
securepubads.g.doubleclick.net
stats.g.doubleclick.net
98 KB
10 ml314.com
ml314.com
in.ml314.com
17 KB
9 googlesyndication.com
tpc.googlesyndication.com
pagead2.googlesyndication.com
401 KB
9 haymarketmedia.com
accounts.haymarketmedia.com
subapi.haymarketmedia.com
adtrackapi.haymarketmedia.com
9 KB
7 google-analytics.com
www.google-analytics.com
41 KB
5 gstatic.com
fonts.gstatic.com
67 KB
5 crwdcntrl.net
tags.crwdcntrl.net
sync.crwdcntrl.net
bcp.crwdcntrl.net
15 KB
4 medtargetsystem.com
www.medtargetsystem.com
52 KB
4 scorecardresearch.com
sb.scorecardresearch.com
3 KB
4 google.com
adservice.google.com
www.google.com
722 B
4 google.de
adservice.google.de
www.google.de
498 B
4 amazonaws.com
s3.amazonaws.com
2 MB
4 googletagservices.com
www.googletagservices.com
99 KB
3 eyeota.net
ps.eyeota.net
1 KB
3 facebook.com
www.facebook.com
247 B
3 sitomobile.com
mt.sitomobile.com
sp.sitomobile.com
2 KB
3 facebook.net
connect.facebook.net
119 KB
3 googleapis.com
fonts.googleapis.com
2 KB
2 mathtag.com
pixel.mathtag.com
1 KB
2 rlcdn.com
idsync.rlcdn.com
440 B
2 adsrvr.org
js.adsrvr.org
insight.adsrvr.org
2 KB
2 tapad.com
pixel.tapad.com
684 B
2 maropost.com
content.maropost.com
mpct1.maropost.com
5 KB
1 chemotherapyadvisor.com
media.chemotherapyadvisor.com
7 KB
1 endocrinologyadvisor.com
media.endocrinologyadvisor.com
6 KB
1 oncologynurseadvisor.com
www.oncologynurseadvisor.com
55 KB
1 rheumatologyadvisor.com
media.rheumatologyadvisor.com
5 KB
1 bluekai.com
tags.bluekai.com
856 B
1 disqus.com
clinicaladvisor.disqus.com
1 KB
1 crazyegg.com
script.crazyegg.com
28 KB
1 native.ai
cdn.native.ai
43 KB
1 googletagmanager.com
www.googletagmanager.com
34 KB
216 36
Domain Requested by
67 c.lytics.io owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com
c.lytics.io
www.clinicaladvisor.com
23 owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com www.clinicaladvisor.com
23 www.clinicaladvisor.com www.clinicaladvisor.com
owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com
9 ml314.com 2 redirects www.clinicaladvisor.com
ml314.com
8 securepubads.g.doubleclick.net 1 redirects www.googletagservices.com
securepubads.g.doubleclick.net
www.clinicaladvisor.com
7 tpc.googlesyndication.com securepubads.g.doubleclick.net
www.clinicaladvisor.com
7 www.google-analytics.com 3 redirects www.googletagmanager.com
www.google-analytics.com
5 subapi.haymarketmedia.com s3.amazonaws.com
5 fonts.gstatic.com www.clinicaladvisor.com
4 api-54-191-43-35.b2c.com 1 redirects www.clinicaladvisor.com
4 api-54-218-77-7.b2c.com 1 redirects www.clinicaladvisor.com
4 api-34-223-224-174.b2c.com 1 redirects www.clinicaladvisor.com
4 www.medtargetsystem.com www.clinicaladvisor.com
www.medtargetsystem.com
4 sb.scorecardresearch.com 1 redirects www.clinicaladvisor.com
www.googletagmanager.com
4 s3.amazonaws.com www.clinicaladvisor.com
4 www.googletagservices.com www.clinicaladvisor.com
securepubads.g.doubleclick.net
3 api.b2c.com securepubads.g.doubleclick.net
www.clinicaladvisor.com
3 adtrackapi.haymarketmedia.com s3.amazonaws.com
3 ps.eyeota.net 2 redirects www.clinicaladvisor.com
3 www.facebook.com www.clinicaladvisor.com
connect.facebook.net
3 www.google.de www.clinicaladvisor.com
3 www.google.com 3 redirects
3 stats.g.doubleclick.net 3 redirects
3 connect.facebook.net www.clinicaladvisor.com
connect.facebook.net
3 fonts.googleapis.com www.clinicaladvisor.com
s3.amazonaws.com
2 bcp.crwdcntrl.net 1 redirects tags.crwdcntrl.net
2 pagead2.googlesyndication.com www.clinicaladvisor.com
2 media.clinicaladvisor.com www.clinicaladvisor.com
2 api.lytics.io c.lytics.io
owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com
2 sync.crwdcntrl.net 2 redirects
2 pixel.mathtag.com 2 redirects
2 idsync.rlcdn.com 2 redirects
2 pixel.tapad.com 2 redirects
2 mt.sitomobile.com 2 redirects
1 insight.adsrvr.org js.adsrvr.org
1 media.chemotherapyadvisor.com www.clinicaladvisor.com
1 media.endocrinologyadvisor.com www.clinicaladvisor.com
1 www.oncologynurseadvisor.com www.clinicaladvisor.com
1 media.rheumatologyadvisor.com www.clinicaladvisor.com
1 tags.bluekai.com 1 redirects
1 in.ml314.com ml314.com
1 accounts.haymarketmedia.com owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com
1 clinicaladvisor.disqus.com owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com
1 mpct1.maropost.com content.maropost.com
1 js.adsrvr.org www.googletagmanager.com
1 sp.sitomobile.com www.clinicaladvisor.com
1 script.crazyegg.com www.googletagmanager.com
1 adservice.google.com www.googletagservices.com
1 adservice.google.de www.googletagservices.com
1 cdn.native.ai owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com
1 content.maropost.com www.clinicaladvisor.com
1 www.googletagmanager.com www.clinicaladvisor.com
1 tags.crwdcntrl.net www.clinicaladvisor.com
1 link.email.clinicaladvisor.com 1 redirects
216 54
Subject Issuer Validity Valid
*.clinicaladvisor.com
RapidSSL RSA CA 2018
2019-02-07 -
2020-02-07
a year crt.sh
*.netdna-ssl.com
Sectigo RSA Domain Validation Secure Server CA
2019-02-18 -
2020-02-27
a year crt.sh
*.googleapis.com
GTS CA 1O1
2019-09-05 -
2019-11-28
3 months crt.sh
tags.crwdcntrl.net
DigiCert SHA2 Secure Server CA
2019-03-15 -
2021-04-07
2 years crt.sh
*.g.doubleclick.net
GTS CA 1O1
2019-09-05 -
2019-11-28
3 months crt.sh
s3.amazonaws.com
DigiCert Baltimore CA-2 G2
2018-12-03 -
2019-10-25
a year crt.sh
*.google-analytics.com
GTS CA 1O1
2019-09-05 -
2019-11-28
3 months crt.sh
content.maropost.com
Amazon
2018-10-25 -
2019-11-25
a year crt.sh
cdn.native.ai
Amazon
2019-08-26 -
2020-09-26
a year crt.sh
*.google.com
GTS CA 1O1
2019-09-05 -
2019-11-28
3 months crt.sh
ssl945600.cloudflaressl.com
COMODO ECC Domain Validation Secure Server CA 2
2019-08-20 -
2020-02-26
6 months crt.sh
*.scorecardresearch.com
COMODO RSA Organization Validation Secure Server CA
2018-11-28 -
2019-12-26
a year crt.sh
*.facebook.com
DigiCert SHA2 High Assurance Server CA
2019-08-24 -
2019-10-19
2 months crt.sh
*.sitomobile.com
RapidSSL RSA CA 2018
2018-01-22 -
2020-07-29
3 years crt.sh
*.adsrvr.org
Trustwave Organization Validation SHA256 CA, Level 1
2019-03-07 -
2021-04-19
2 years crt.sh
*.maropost.com
Go Daddy Secure Certificate Authority - G2
2019-06-10 -
2021-08-09
2 years crt.sh
*.disqus.com
DigiCert SHA2 Secure Server CA
2018-03-28 -
2020-04-27
2 years crt.sh
ssl379818.cloudflaressl.com
COMODO ECC Domain Validation Secure Server CA 2
2019-07-26 -
2020-02-01
6 months crt.sh
accounts.haymarketmedia.com
Amazon
2018-10-26 -
2019-11-26
a year crt.sh
medtargetsystem.com
Amazon
2018-11-23 -
2019-12-23
a year crt.sh
*.ml314.com
Amazon
2019-03-16 -
2020-04-16
a year crt.sh
www.google.de
GTS CA 1O1
2019-09-05 -
2019-11-28
3 months crt.sh
*.eyeota.net
Let's Encrypt Authority X3
2019-09-19 -
2019-12-18
3 months crt.sh
*.lytics.io
RapidSSL TLS RSA CA G1
2018-01-26 -
2020-01-06
2 years crt.sh
subapi.haymarketmedia.com
Amazon
2019-06-28 -
2020-07-28
a year crt.sh
tpc.googlesyndication.com
GTS CA 1O1
2019-09-05 -
2019-11-28
3 months crt.sh
rheumatologyadvisor.com
Amazon
2018-11-08 -
2019-12-08
a year crt.sh
*.oncologynurseadvisor.com
RapidSSL RSA CA 2018
2019-02-07 -
2020-02-07
a year crt.sh
endocrinologyadvisor.com
Amazon
2018-11-08 -
2019-12-08
a year crt.sh
chemotherapyadvisor.com
Amazon
2018-11-14 -
2019-12-14
a year crt.sh
clinicaladvisor.com
Amazon
2018-11-09 -
2019-12-09
a year crt.sh
adtrackapi.haymarketmedia.com
Amazon
2019-03-27 -
2020-04-27
a year crt.sh
*.b2c.com
Amazon
2019-03-24 -
2020-04-24
a year crt.sh
*.crwdcntrl.net
Go Daddy Secure Certificate Authority - G2
2019-06-13 -
2021-06-28
2 years crt.sh

This page contains 10 frames:

Primary Page: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Frame ID: EB55DB510851209FC4CAD4AB88FD530C
Requests: 195 HTTP requests in this frame

Frame: https://api.lytics.io/api/me/iframe/43bffbce6f25564c8e2145a11836ff9f/_uid/4d17370bde885f6acda1f3268cfe6917?segments=true&mergestate=true&ts=1568941783595
Frame ID: 8BE87BE27E4FFA11B788347ABA4160AA
Requests: 1 HTTP requests in this frame

Frame: https://www.facebook.com/tr/
Frame ID: 3219270DE717C1BF96448F929919FBB3
Requests: 1 HTTP requests in this frame

Frame: https://www.medtargetsystem.com/beacon/portal/?_url=https%3A%2F%2Fwww.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F&_sid=b708509b-3740-422b-a487-851422be3d93&_vid=ec41240c-8c9e-4a22-a70c-c578fadded2e&_ak=35-213-196850D0&_flash=false&_th=1568941783|1568941783|1
Frame ID: F96035DDC8AC53DEE3DA18A8AAEC9253
Requests: 1 HTTP requests in this frame

Frame: https://www.facebook.com/tr/
Frame ID: 9A1B73DFECD2C617A89A0D73582A7AE5
Requests: 1 HTTP requests in this frame

Frame: data://truncated
Frame ID: 08C86D929DA5B5ECCF00283ADF837A10
Requests: 1 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstAz0sukIGNOQdZpUQco2UEYuVC_hi1zxWMRcSWs6meS6zGrTTM9utphmVl6cdXL8H7AaPTTn01vaKZiLu8kTPYrCfnwgGYaOqJF9wil4b8lgi4rqKt03XrUjLbAT6Sm3RTWiDDhXj0hLySLWTQ1M7OYmH4LYi5xYOws3bPHBaDcJ4H-LMDxgMnS5HRHKbCfUo6Ns1GRsvRorgTM6QoAdUvZcB5BBBOmDvhDkJVBbALw-HoMtmLx8MqpLS26lDqC0Nxq6DV6ik42nlSMfse47Q7vR3EvZIgeLn2YO8kdVW4xpp8A5UYICX1C0WjBFdeJZBXz5-48PevezuoP_L2DZN73Xi6qvevIjI&sig=Cg0ArKJSzMc28QOZ6NbfEAE&adurl=
Frame ID: DD1D82FD1757A0FD631B0A8A24329956
Requests: 10 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/pagead/js/r20190918/r20110914/client/error_handler.js
Frame ID: 5571CF953FFC75CA7D51E3786FD50F25
Requests: 11 HTTP requests in this frame

Frame: https://bcp.crwdcntrl.net/5/ct=y/c=14419/rand=851428171/pv=y/ver=1.4/int=%23OpR%2396858%23Total%20Site%20Traffic%20%3A%20www.clinicaladvisor.com/int=%23OpR%2396859%23www.clinicaladvisor.com%20%3A%20Site%20Section%20%3A%20home/int=%23OpR%2396860%23www.clinicaladvisor.com%20%3A%20Site%20Section%20%3A%20home%20%20%3A%20topics/int=%23OpR%2397492%23www.clinicaladvisor.com%20%3A%20Site%20Section%20%3A%20home%20%3A%20topics%20%3A%20allergy-and-immunology-information-center/int=%23OpR%2397493%23www.clinicaladvisor.com%20%3A%20Site%20Section%20%3A%20home%20%3A%20topics%20%3A%20allergy-and-immunology-information-center%20%3A%20fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/act=%23OpR%2397530%23www.clinicaladvisor.com%20%3A%20Sign%20Up%20for%20Free%20E-News%20Letter/med=%23OpR%2397539%23Article%20Tags%20%3A%20Allergy%20%26%20Immunology/rb=%7B%22url%22%3A%22https%3A%2F%2Fwww.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181%22%7D/rt=ifr
Frame ID: D6968563A3A659482B5A415CD6F826EC
Requests: 1 HTTP requests in this frame

Frame: https://insight.adsrvr.org/track/up?adv=wxli9bh&ref=https%3A%2F%2Fwww.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&upid=narppxi&upv=1.1.0
Frame ID: E476623E182EB3EAFC01D89CCC29109E
Requests: 1 HTTP requests in this frame

Screenshot


Page URL History Show full URLs

  1. http://link.email.clinicaladvisor.com/a/1323/click/68670/2332181/7c3a4d985e81847c86d9bf2fe834451d4a19f32f/f2e2cf5d... HTTP 302
    https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-dr... Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
  • headers link /rel="https:\/\/api\.w\.org\/"/i

Overall confidence: 100%
Detected patterns
  • headers link /rel="https:\/\/api\.w\.org\/"/i

Overall confidence: 100%
Detected patterns
  • headers link /rel="https:\/\/api\.w\.org\/"/i

Overall confidence: 100%
Detected patterns
  • headers server /nginx(?:\/([\d.]+))?/i

Overall confidence: 100%
Detected patterns
  • script /script\.crazyegg\.com\/pages\/scripts\/\d+\/\d+\.js/i

Overall confidence: 100%
Detected patterns
  • script /\/\/connect\.facebook\.net\/[^\/]*\/[a-z]*\.js/i

Overall confidence: 100%
Detected patterns
  • script /google-analytics\.com\/(?:ga|urchin|analytics)\.js/i

Overall confidence: 100%
Detected patterns
  • html /googletagmanager\.com\/ns\.html[^>]+><\/iframe>/i
  • html /<!-- (?:End )?Google Tag Manager -->/i

Page Statistics

216
Requests

100 %
HTTPS

37 %
IPv6

36
Domains

54
Subdomains

47
IPs

7
Countries

11464 kB
Transfer

13853 kB
Size

0
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. http://link.email.clinicaladvisor.com/a/1323/click/68670/2332181/7c3a4d985e81847c86d9bf2fe834451d4a19f32f/f2e2cf5d21125c5eff6ae819bb999240cbb8a415&amp HTTP 302
    https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181 Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 39
  • https://sb.scorecardresearch.com/b?c1=2&c2=21948019&ns__t=1568941782904&ns_c=UTF-8&c8=FDA%20to%20Assess%20First%20Drug%20Meant%20to%20Prevent%20Peanut%20Allergy%20-%20Clinical%20Advisor&c7=https%3A%2F%2Fwww.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&c9= HTTP 302
  • https://sb.scorecardresearch.com/b2?c1=2&c2=21948019&ns__t=1568941782904&ns_c=UTF-8&c8=FDA%20to%20Assess%20First%20Drug%20Meant%20to%20Prevent%20Peanut%20Allergy%20-%20Clinical%20Advisor&c7=https%3A%2F%2Fwww.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&c9=
Request Chain 49
  • https://mt.sitomobile.com/sync/ta?aid=136&sid=hmm&val=4 HTTP 302
  • https://pixel.tapad.com/idsync/ex/push?partner_id=2822&partner_url=https%3A%2F%2Fmt.sitomobile.com%2Fsync%2Ftacb%3Fexid%3D%24%7BTA_DEVICE_ID%7D%26aid%3D136%26sid%3Dhmm%26val%3D4 HTTP 302
  • https://pixel.tapad.com/idsync/ex/push/check?partner_id=2822&partner_url=https%3A%2F%2Fmt.sitomobile.com%2Fsync%2Ftacb%3Fexid%3D%24%7BTA_DEVICE_ID%7D%26aid%3D136%26sid%3Dhmm%26val%3D4 HTTP 302
  • https://mt.sitomobile.com/sync/tacb?exid=5440b791-db43-11e9-a060-0a88419facc3&aid=136&sid=hmm&val=4 HTTP 302
  • https://sp.sitomobile.com/i?tna=sito&p=mob&e=ue&ue_px=eyJzY2hlbWEiOiJpZ2x1OmNvbS5zbm93cGxvd2FuYWx5dGljcy5zbm93cGxvdy91bnN0cnVjdF9ldmVudC9qc29uc2NoZW1hLzEtMC0wIiwiZGF0YSI6eyJzY2hlbWEiOiJpZ2x1OmNvbS5zaXRvbW9iaWxlLnNub3dwbG93L2Nvb2tpZV9zeW5jL2pzb25zY2hlbWEvMS0wLTAiLCJkYXRhIjp7InBhcnRuZXJJZCI6InRhcGFkIn19fQ%3D%3D&cx=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
Request Chain 63
  • https://www.google-analytics.com/r/collect?v=1&_v=j79&a=1445100269&t=pageview&_s=1&dl=https%3A%2F%2Fwww.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&ul=en-us&de=UTF-8&dt=FDA%20to%20Assess%20First%20Drug%20Meant%20to%20Prevent%20Peanut%20Allergy%20-%20Clinical%20Advisor&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&_u=aGDAAAAjQ~&jid=2109231193&gjid=1228871920&cid=719138576.1568941783&tid=UA-1290429-4&_gid=201143169.1568941783&_r=1&gtm=2wg9b0PXC3M3S&cd1=94006%3A0&cd2=allergy%20%26amp%3B%20immunology&cd3=&cd4=&cd5=post&cd6=&cd7=home&cd8=topics&cd9=allergy%20and%20immunology%20information%20center&cd10=fda%20to%20assess%20first%20drug%20meant%20to%20prevent%20peanut%20allergy&cd11=omn&cd12=6&cd14=false&cd15=&cd16=false&cd17=&cd18=0&cd19=&cd31=&cd32=&cd33=&cd34=&cd35=Healthday&cd36=&cd37=undefined&cd38=undefined&cd39=undefined&cd40=&cd41=&cd42=&cd43=&cd46=&cd48=&cd50=&cd52=&cd53=home&cd54=&cd55=&cd56=11&cd57=&cd58=&cd61=false&cd62=2019-09-17&cd63=231&cd66=&cd67=undef&cd70=false&cd89=false&cd90=false&cd91=false&cd92=allergy%20and%20immunology%20information%20center%2Cnews&z=1855722087 HTTP 302
  • https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-1290429-4&cid=719138576.1568941783&jid=2109231193&_gid=201143169.1568941783&gjid=1228871920&_v=j79&z=1855722087 HTTP 302
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-4&cid=719138576.1568941783&jid=2109231193&_v=j79&z=1855722087 HTTP 302
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-4&cid=719138576.1568941783&jid=2109231193&_v=j79&z=1855722087&slf_rd=1&random=3883267600
Request Chain 68
  • https://tags.bluekai.com/site/20486?limit=0&id=5978151499129049387&redir=https://ml314.com/csync.ashx%3Ffp=$_BK_UUID%26person_id=5978151499129049387%26eid=50056 HTTP 302
  • https://ml314.com/csync.ashx?fp=q48tmQ9999eH5GH5&person_id=5978151499129049387&eid=50056
Request Chain 69
  • https://idsync.rlcdn.com/395886.gif?partner_uid=5978151499129049387 HTTP 307
  • https://idsync.rlcdn.com/1000.gif?memo=CO6UGBIeChoIARCuXxoTNTk3ODE1MTQ5OTEyOTA0OTM4NxAAGg0I182Q7AUSBQjoBxAAQgBKAA HTTP 307
  • https://ml314.com/csync.ashx?fp=&person_id=5978151499129049387&eid=50082
Request Chain 70
  • https://pixel.mathtag.com/sync/img?redir=https://ml314.com/csync.ashx%3Ffp=[MM_UUID]%26person_id=5978151499129049387%26eid=50220 HTTP 302
  • https://pixel.mathtag.com/sync/img?redir=https://ml314.com/csync.ashx%3Ffp=[MM_UUID]%26person_id=5978151499129049387%26eid=50220&mm_bnc&mm_bct&UUID=16575d84-16e8-4600-89b1-cff494536fe4 HTTP 302
  • https://ml314.com/csync.ashx?fp=16575d84-16e8-4600-89b1-cff494536fe4&person_id=5978151499129049387&eid=50220
Request Chain 71
  • https://sync.crwdcntrl.net/map/c=6985/tp=BOMB?https://ml314.com/csync.ashx%3Ffp%3D%24%7Bprofile_id%7D%26eid%3D50146%26person_id%3D5978151499129049387 HTTP 302
  • https://sync.crwdcntrl.net/map/ct=y/c=6985/tp=BOMB?https://ml314.com/csync.ashx%3Ffp%3D%24%7Bprofile_id%7D%26eid%3D50146%26person_id%3D5978151499129049387 HTTP 302
  • https://ml314.com/csync.ashx?fp=31a2d085fe5b6cb16bdbff102dc4eaab&eid=50146&person_id=5978151499129049387
Request Chain 72
  • https://ps.eyeota.net/pixel?pid=r8hrb20&t=gif HTTP 302
  • https://ps.eyeota.net/pixel/bounce/?pid=r8hrb20&t=gif HTTP 302
  • https://ml314.com/utsync.ashx?eid=50052&et=0&fp=2fcdtmnSd5DdgXN9bsE4uhqBsLq2UvAScb1MqGdAZAYU&gdpr=1&gdpr_consent=&return=https%3A%2F%2Fps.eyeota.net%2Fmatch%3Fbid%3Dr8hrb20%26uid%3Dnil HTTP 302
  • https://ml314.com/csync.ashx?fp=2fcdtmnSd5DdgXN9bsE4uhqBsLq2UvAScb1MqGdAZAYU&person_id=5978151499129049387&eid=50052&return=https%3a%2f%2fps.eyeota.net%2fmatch%3fbid%3dr8hrb20%26uid%3dnil HTTP 302
  • https://ps.eyeota.net/match?bid=r8hrb20&uid=nil
Request Chain 181
  • https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsud5pqNuFOUtH8ZgaMd9-0-qtlAZuDhS98uxD5zBGrWPgX8TcH1ntXmENh-dBQjDU4qQeCJ2Ph4IO6v_q8APmsyEt4h3v25lkgkd8a3-QlW8kbPz2B0ipe3BAkJoPT6J4Fmmw7pvEfdE07OECmN9r8qSzj3M4aaYXVgIWGwrRe3XvYTrSy5f-Y9XgMCnS9FK248eh5e5HubxD2pNYX1WLkTD3WmqF6yziOp7-vgpDduSw1nhVs6i1q5QdIiigp80cALVjqe2xu--PgC21Eq7NX0IXtIXOZ7OGKJQQOKe15OrPYZI-q2FsCgYHHzkQ8WupRwDffS7U_wjcoRowJI6C93SrsXHUH5ThNUcUrYCkpoB7wt7dA4eP1NG_u_UgEOUhzdCgLN&sai=AMfl-YQfQnbctJyKsuIzS2yflV6h7LJoDAUAi5Iwo3Oyxl4M0fJVEQoiTBWmsM2inxcbAmsq6azMyuJ7K7Mk0ZQIPVJkAugKbT-wqVkWmba8&sig=Cg0ArKJSzL0UinYwgLbvEAE&urlfix=1&adurl=https://tpc.googlesyndication.com/pagead/imgad?id=CICAgKDHyqHSjgEQARgBMghpUBQmFaL9aw HTTP 302
  • https://tpc.googlesyndication.com/pagead/imgad?id=CICAgKDHyqHSjgEQARgBMghpUBQmFaL9aw
Request Chain 205
  • https://api-34-223-224-174.b2c.com/api/x?WF72lbkw1EnkX9a3$dXJsJDAkaHR0cHM6Ly93d3cuY2xpbmljYWxhZHZpc29yLmNvbS9ob21lL3RvcGljcy9hbGxlcmd5LWFuZC1pbW11bm9sb2d5LWluZm9ybWF0aW9uLWNlbnRlci9mZGEtdG8tYXNzZXNzLWZpcnN0LWRydWctbWVhbnQtdG8tcHJldmVudC1wZWFudXQtYWxsZXJneS8_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 HTTP 302
  • https://api-34-223-224-174.b2c.com:444/api/4?WF72lbkw1EnkX9a3
Request Chain 206
  • https://api-54-218-77-7.b2c.com/api/x?K3qQnNwvX7UGcE7F$dXJsJDAkaHR0cHM6Ly93d3cuY2xpbmljYWxhZHZpc29yLmNvbS9ob21lL3RvcGljcy9hbGxlcmd5LWFuZC1pbW11bm9sb2d5LWluZm9ybWF0aW9uLWNlbnRlci9mZGEtdG8tYXNzZXNzLWZpcnN0LWRydWctbWVhbnQtdG8tcHJldmVudC1wZWFudXQtYWxsZXJneS8_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 HTTP 302
  • https://api-54-218-77-7.b2c.com:444/api/4?K3qQnNwvX7UGcE7F
Request Chain 211
  • https://bcp.crwdcntrl.net/5/c=14419/rand=851428171/pv=y/ver=1.4/int=%23OpR%2396858%23Total%20Site%20Traffic%20%3A%20www.clinicaladvisor.com/int=%23OpR%2396859%23www.clinicaladvisor.com%20%3A%20Site%20Section%20%3A%20home/int=%23OpR%2396860%23www.clinicaladvisor.com%20%3A%20Site%20Section%20%3A%20home%20%20%3A%20topics/int=%23OpR%2397492%23www.clinicaladvisor.com%20%3A%20Site%20Section%20%3A%20home%20%3A%20topics%20%3A%20allergy-and-immunology-information-center/int=%23OpR%2397493%23www.clinicaladvisor.com%20%3A%20Site%20Section%20%3A%20home%20%3A%20topics%20%3A%20allergy-and-immunology-information-center%20%3A%20fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/act=%23OpR%2397530%23www.clinicaladvisor.com%20%3A%20Sign%20Up%20for%20Free%20E-News%20Letter/med=%23OpR%2397539%23Article%20Tags%20%3A%20Allergy%20%26%20Immunology/rb=%7B%22url%22%3A%22https%3A%2F%2Fwww.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181%22%7D/rt=ifr HTTP 302
  • https://bcp.crwdcntrl.net/5/ct=y/c=14419/rand=851428171/pv=y/ver=1.4/int=%23OpR%2396858%23Total%20Site%20Traffic%20%3A%20www.clinicaladvisor.com/int=%23OpR%2396859%23www.clinicaladvisor.com%20%3A%20Site%20Section%20%3A%20home/int=%23OpR%2396860%23www.clinicaladvisor.com%20%3A%20Site%20Section%20%3A%20home%20%20%3A%20topics/int=%23OpR%2397492%23www.clinicaladvisor.com%20%3A%20Site%20Section%20%3A%20home%20%3A%20topics%20%3A%20allergy-and-immunology-information-center/int=%23OpR%2397493%23www.clinicaladvisor.com%20%3A%20Site%20Section%20%3A%20home%20%3A%20topics%20%3A%20allergy-and-immunology-information-center%20%3A%20fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/act=%23OpR%2397530%23www.clinicaladvisor.com%20%3A%20Sign%20Up%20for%20Free%20E-News%20Letter/med=%23OpR%2397539%23Article%20Tags%20%3A%20Allergy%20%26%20Immunology/rb=%7B%22url%22%3A%22https%3A%2F%2Fwww.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181%22%7D/rt=ifr
Request Chain 215
  • https://www.google-analytics.com/r/collect?v=1&_v=j79&a=1445100269&t=event&ni=1&_s=1&dl=https%3A%2F%2Fwww.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&ul=en-us&de=UTF-8&dt=FDA%20to%20Assess%20First%20Drug%20Meant%20to%20Prevent%20Peanut%20Allergy%20-%20Clinical%20Advisor&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&ec=lytics_refresh&ea=undefined&_u=aGjAAAAjQ~&jid=1085905300&gjid=402992205&cid=719138576.1568941783&tid=UA-1290429-4&_gid=1959208939.1568941789&_r=1&gtm=2wg9b0PXC3M3S&cd20=ga_med_nomycme%2Cga_med_nht_false%2Call%2Cga_med_known&cd21=&cd22=&cd23=&cd24=&cd25=&cd26=&cd27=&cd28=&cd29=&cd30=Normal%20(72%20segments%20found)&z=987241644 HTTP 302
  • https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-1290429-4&cid=719138576.1568941783&jid=1085905300&_gid=1959208939.1568941789&gjid=402992205&_v=j79&z=987241644 HTTP 302
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-4&cid=719138576.1568941783&jid=1085905300&_v=j79&z=987241644 HTTP 302
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-4&cid=719138576.1568941783&jid=1085905300&_v=j79&z=987241644&slf_rd=1&random=3244639344
Request Chain 218
  • https://api-54-191-43-35.b2c.com/api/x?6d9jARngt8b43j1F$dXJsJDAkaHR0cHM6Ly93d3cuY2xpbmljYWxhZHZpc29yLmNvbS9ob21lL3RvcGljcy9hbGxlcmd5LWFuZC1pbW11bm9sb2d5LWluZm9ybWF0aW9uLWNlbnRlci9mZGEtdG8tYXNzZXNzLWZpcnN0LWRydWctbWVhbnQtdG8tcHJldmVudC1wZWFudXQtYWxsZXJneS8_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 HTTP 302
  • https://api-54-191-43-35.b2c.com:444/api/4?6d9jARngt8b43j1F
Request Chain 220
  • https://www.google-analytics.com/r/collect?v=1&_v=j79&a=1445100269&t=event&ni=0&_s=1&dl=https%3A%2F%2Fwww.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&ul=en-us&de=UTF-8&dt=FDA%20to%20Assess%20First%20Drug%20Meant%20to%20Prevent%20Peanut%20Allergy%20-%20Clinical%20Advisor&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&ec=User%20Engagement&ea=Beacon&_u=aGjAAAAjQ~&jid=494651994&gjid=1453491562&cid=719138576.1568941783&tid=UA-1290429-4&_gid=1891035648.1568941798&_r=1&gtm=2wg9b0PXC3M3S&cd13=No&z=233739712 HTTP 302
  • https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-1290429-4&cid=719138576.1568941783&jid=494651994&_gid=1891035648.1568941798&gjid=1453491562&_v=j79&z=233739712 HTTP 302
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-4&cid=719138576.1568941783&jid=494651994&_v=j79&z=233739712 HTTP 302
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-4&cid=719138576.1568941783&jid=494651994&_v=j79&z=233739712&slf_rd=1&random=1351949555

216 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Primary Request /
www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/
Redirect Chain
  • http://link.email.clinicaladvisor.com/a/1323/click/68670/2332181/7c3a4d985e81847c86d9bf2fe834451d4a19f32f/f2e2cf5d21125c5eff6ae819bb999240cbb8a415&amp
  • https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=c...
103 KB
21 KB
Document
General
Full URL
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
e7387f6fc12dc7de9818a45bf80b7ba941ace211dfb95967ff694e925f87ad57

Request headers

:method
GET
:authority
www.clinicaladvisor.com
:scheme
https
:path
/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
none
accept-encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
server
nginx
date
Fri, 20 Sep 2019 01:09:42 GMT
content-type
text/html; charset=UTF-8
vary
Accept-Encoding Accept-Encoding Accept-Encoding,Cookie,X-WPENGINE-SEGMENT
x-distributor
yes
x-pingback
https://www.clinicaladvisor.com/xmlrpc.php
link
<https://www.clinicaladvisor.com/wp-json/>; rel="https://api.w.org/" <https://www.clinicaladvisor.com/?p=94006>; rel=shortlink
x-cacheable
SHORT
cache-control
max-age=600, must-revalidate
x-cache
HIT: 1
x-pass-why
x-cache-group
normal
x-wpengine-segment
NONHT
content-encoding
gzip

Redirect headers

Content-Type
text/html; charset=utf-8
Transfer-Encoding
chunked
Connection
keep-alive
Status
302 Found
Cache-Control
no-cache
X-XSS-Protection
1; mode=block
X-Request-Id
c8b01c94-9cf0-44d5-8111-0a994d14a71f
Location
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
X-Runtime
0.024305
X-Frame-Options
SAMEORIGIN
X-Content-Type-Options
nosniff
Date
Fri, 20 Sep 2019 01:09:42 GMT
Set-Cookie
_session_id=d27c1b6e7a97b8f5c658079d9bad8ede; path=/; expires=Fri, 20 Sep 2019 13:09:42 -0000; HttpOnly
X-Powered-By
Phusion Passenger 5.3.4
Server
nginx/1.14.0 + Phusion Passenger 5.3.4
style.min.css
owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-includes/css/dist/block-library/
29 KB
5 KB
Stylesheet
General
Full URL
https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-includes/css/dist/block-library/style.min.css?ver=5.2.3
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
4b8fe5c3d0e5ef7a6582185cbf5c535b5d369c8df1da98c03ed69833e55f474d

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:42 GMT
content-encoding
gzip
last-modified
Mon, 22 Apr 2019 12:40:04 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5cbdb624-726f"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
shared-style.min.css
owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/
48 KB
7 KB
Stylesheet
General
Full URL
https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/shared-style.min.css?ver=1553589230
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
33fe4fe8214760f15a5fdd753b5c396ee5b916e5d6f66f79d4765ed260706723

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:42 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5c99e3ee-c05a"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
style.min.css
owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/
240 KB
32 KB
Stylesheet
General
Full URL
https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/style.min.css?ver=1567085297
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
f1e3884dae2f0ddd32795c0c1ac83e9f9a8c7dce35dbd784bdc3c9872196bb1c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:42 GMT
content-encoding
gzip
last-modified
Thu, 29 Aug 2019 13:28:17 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d67d2f1-3bfb4"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
css
fonts.googleapis.com/
8 KB
861 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Helvetica:400,400i,700,700i
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:809::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
c2565fd7668cbf03896fdc38bf7ccaa44fe606cb64dd45ee8cb2e591eeeb393c
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Fri, 20 Sep 2019 01:09:42 GMT
server
ESF
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
status
200
date
Fri, 20 Sep 2019 01:09:42 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
x-xss-protection
0
expires
Fri, 20 Sep 2019 01:09:42 GMT
lytics.min.css
owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/
39 KB
3 KB
Stylesheet
General
Full URL
https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/lytics.min.css?ver=1567085297
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
6944e75951f2e7bf00121eea502e7d952a833e811e13a1f28fb077df6af721f3

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:42 GMT
content-encoding
gzip
last-modified
Thu, 29 Aug 2019 13:28:17 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d67d2f1-9de9"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
css
fonts.googleapis.com/
825 B
466 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Bree+Serif&ver=0.1.1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:809::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
19aa6c614f72f6bb67cb17a6169ca551686c2bab5475293c95880f5f32cd830e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Fri, 20 Sep 2019 01:09:42 GMT
server
ESF
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
status
200
date
Fri, 20 Sep 2019 01:09:42 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
x-xss-protection
0
expires
Fri, 20 Sep 2019 01:09:42 GMT
jquery.js
owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-includes/js/jquery/
95 KB
34 KB
Script
General
Full URL
https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-includes/js/jquery/jquery.js?ver=1.12.4-wp
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
1db21d816296e6939ba1f42962496e4134ae2b0081e26970864c40c6d02bb1df

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:42 GMT
content-encoding
gzip
last-modified
Fri, 17 May 2019 17:08:53 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5cdeeaa5-17a69"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
jquery-migrate.min.js
owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-includes/js/jquery/
10 KB
4 KB
Script
General
Full URL
https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-includes/js/jquery/jquery-migrate.min.js?ver=1.4.1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
48eb8b500ae6a38617b5738d2b3faec481922a7782246e31d2755c034a45cd5d

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:42 GMT
content-encoding
gzip
last-modified
Fri, 20 May 2016 06:11:28 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"573eaa90-2748"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
cookie.min.js
owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/mu-plugins/cookie-controller/js/
2 KB
1 KB
Script
General
Full URL
https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/mu-plugins/cookie-controller/js/cookie.min.js?ver=1.2
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
e828282e92509efc0f7bc57888382c5816bd403e0abbb685eda5c4372cc7daa5

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:42 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5c99e3ee-834"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
cc.js
tags.crwdcntrl.net/c/14419/
39 KB
11 KB
Script
General
Full URL
https://tags.crwdcntrl.net/c/14419/cc.js?ver=1.4&ns=_cc14419
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
93.184.220.113 London, United Kingdom, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/4190) /
Resource Hash
ad2cddfae46f92edf3f49da149c843df69b71027a67530297990371062213254

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:42 GMT
content-encoding
gzip
last-modified
Thu, 12 Sep 2019 01:01:48 GMT
server
ECS (fcn/4190)
etag
"5d7998fc-9b68+gzip"
vary
Accept-Encoding
x-cache
HIT
content-type
application/javascript
status
200
cache-control
max-age=86400
content-length
11493
expires
Sat, 21 Sep 2019 01:09:42 GMT
hm-nativeai-tracking-tag.js
owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/plugins/hm-nativeai-tracker/js/
464 B
592 B
Script
General
Full URL
https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/plugins/hm-nativeai-tracker/js/hm-nativeai-tracking-tag.js?ver=1.0
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
2807f5cbf1548ebb34b91cdb486e629a6a36fc85d2f250803f5b12f8bebb6b35

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:42 GMT
content-encoding
gzip
last-modified
Wed, 10 Jul 2019 08:59:26 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d25a8ee-1d0"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
digest.min.js
owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/
16 KB
5 KB
Script
General
Full URL
https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/digest.min.js?ver=2.1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
b3c617e4ee00489d6fb85a53bd88cb1e1f5e71ae5244c54a7fea6b6e7d9921ad

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:42 GMT
content-encoding
gzip
last-modified
Wed, 22 May 2019 09:37:40 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5ce51864-3fc1"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
UtilityMove-custom.min.js
owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/vendor/
2 KB
1 KB
Script
General
Full URL
https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/vendor/UtilityMove-custom.min.js?ver=1553589230
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
cffef365e4b53f1a6e9d33a7d42c0d1542b573360f774069589240f75f0e84f1

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:42 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5c99e3ee-751"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
polyfill.min.js
owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/js/frontend/
102 KB
35 KB
Script
General
Full URL
https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/js/frontend/polyfill.min.js?ver=1553589230
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
59173f786dd1f3802f7ab26fd339aac4099dc10c6cb54a6a92213e6af277592a

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:42 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5c99e3ee-19873"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
gpt.js
www.googletagservices.com/tag/js/
40 KB
13 KB
Script
General
Full URL
https://www.googletagservices.com/tag/js/gpt.js
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:818::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
6ca19d70def89831ee636a9a0ff20430686597eacf06f0d6253b5babc5f72e9f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:42 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"284 / 777 of 1000 / last-modified: 1568909619"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
12708
x-xss-protection
0
expires
Fri, 20 Sep 2019 01:09:42 GMT
adtracking.js
s3.amazonaws.com/haymarket-adtracking-js/prod/
19 KB
19 KB
Script
General
Full URL
https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.177.205 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
s3-1.amazonaws.com
Software
AmazonS3 /
Resource Hash
822847109c3aaf484affe599900514bcf4167ceda17fcca7a97b691d780dae25

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 20 Sep 2019 01:09:44 GMT
Last-Modified
Tue, 15 Jan 2019 22:54:19 GMT
Server
AmazonS3
x-amz-request-id
CE813D16725B0D87
ETag
"dc289fc811d6d3a62b068bfcda1f8f30"
Content-Type
application/javascript
x-amz-version-id
MlU6AsBGwcOjZYgQIgNYntESpQyo9BbN
Accept-Ranges
bytes
Content-Length
19158
x-amz-id-2
HUvDXcyly+uhGN+aZHKWUqPRWdAqvsw+JkGutRYf2tWf/Ts6CWusQ6XJb4vIP3neh33X6GjkBpw=
head.min.js
owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/
44 KB
13 KB
Script
General
Full URL
https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/head.min.js?ver=1568281912
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
454b56eb2367b33e6f99edc171815d9a69267263af086b343b8b8aad13ed4c63

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:42 GMT
content-encoding
gzip
last-modified
Thu, 12 Sep 2019 09:51:52 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d7a1538-ae1e"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
logo684531_784586.png
owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/uploads/sites/11/2018/12/
3 KB
3 KB
Image
General
Full URL
https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/uploads/sites/11/2018/12/logo684531_784586.png
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
8b4369153780828bff5de99459130adede56d907d9ac3a2275a22ac249d9fe4e
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:42 GMT
etag
"eadf834d8c459e208192ff57b5ff59ea"
last-modified
Fri, 22 Mar 2019 12:23:49 GMT
server
NetDNA-cache/2.2
x-amz-server-side-encryption
AES256
x-frame-options
SAMEORIGIN
x-cache
HIT
content-type
image/png
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
2946
expires
Sat, 19 Oct 2019 17:53:35 GMT
gtm.js
www.googletagmanager.com/
135 KB
34 KB
Script
General
Full URL
https://www.googletagmanager.com/gtm.js?id=GTM-PXC3M3S
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:820::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
d8248875d14e3b70278ef0e64cb5b91e95358fe9a193f61d6626ded061b20a5c
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:42 GMT
content-encoding
br
last-modified
Fri, 20 Sep 2019 00:00:00 GMT
server
Google Tag Manager
access-control-allow-headers
Cache-Control
status
200
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
http://www.googletagmanager.com
cache-control
private, max-age=900
access-control-allow-credentials
true
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
34520
x-xss-protection
0
expires
Fri, 20 Sep 2019 01:09:42 GMT
peanutallergypreventionts5_1129621-860x574.jpg
owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/uploads/sites/11/2019/02/
70 KB
70 KB
Image
General
Full URL
https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/uploads/sites/11/2019/02/peanutallergypreventionts5_1129621-860x574.jpg
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
f1837647edb81205515d8dfe198f117d999a79f2875a9be6d0823409b6840004
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:43 GMT
etag
"69562e6b6007d5578e348aaff26477be"
last-modified
Fri, 22 Mar 2019 08:18:49 GMT
server
NetDNA-cache/2.2
x-amz-server-side-encryption
AES256
x-frame-options
SAMEORIGIN
x-cache
MISS
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
71661
expires
Sun, 20 Oct 2019 01:09:43 GMT
spinner.svg
www.clinicaladvisor.com/wp-content/themes/haymarket/assets/svg/src/
694 B
631 B
Image
General
Full URL
https://www.clinicaladvisor.com/wp-content/themes/haymarket/assets/svg/src/spinner.svg
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
abb1dd7905b3797711e15609800d43cabead4c0358dc0030a1932a20e82a37d7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:42 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
nginx
status
200
etag
W/"5c99e3ee-2b6"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
public, max-age=31536000
peanutsts496857220_1110922-150x150.jpg
owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/uploads/sites/11/2018/12/
10 KB
11 KB
Image
General
Full URL
https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/uploads/sites/11/2018/12/peanutsts496857220_1110922-150x150.jpg
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
f1e34715881c99c73d823e74acf1c245fbf904a790d19acc2370a87e1a392d44
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:43 GMT
etag
"65a2ba86ac9f8f18f760baf17cde2dd6"
last-modified
Fri, 22 Mar 2019 10:38:40 GMT
server
NetDNA-cache/2.2
x-amz-server-side-encryption
AES256
x-frame-options
SAMEORIGIN
x-cache
MISS
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
10473
expires
Sun, 20 Oct 2019 01:09:43 GMT
004d8e84d92b918c58eddfb8f83206a17a287497-v2.js
content.maropost.com/uploads/1323/websites/1/
3 KB
3 KB
Script
General
Full URL
https://content.maropost.com/uploads/1323/websites/1/004d8e84d92b918c58eddfb8f83206a17a287497-v2.js?ver=1.1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:20bb:7000:1b:fadc:b780:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
a7cec0f75ab1f4ad03a490ccf6384070ed97b1082e4ba45c20a44a7278e03d8b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 15 Sep 2019 16:13:02 GMT
via
1.1 94d63cbf92082237b86267ffd4cacc64.cloudfront.net (CloudFront)
last-modified
Thu, 27 Sep 2018 21:47:57 GMT
server
AmazonS3
age
26424
etag
"6a4f2e745068f425515d059e669b81ea"
x-cache
Hit from cloudfront
status
200
x-amz-cf-pop
FRA56
accept-ranges
bytes
content-length
2622
x-amz-cf-id
ctjRbQD1DFoTfwDXNFxvmOduk_D7WGzR5tpkAB8IuC_8HP49UZ6JWA==
blocks.min.js
owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/
7 KB
3 KB
Script
General
Full URL
https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/blocks.min.js?ver=1567085297
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
3ed3de3fd0fabc795d8b96ada205998944ff3157366f20b70d5d10b099b63120

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:42 GMT
content-encoding
gzip
last-modified
Thu, 29 Aug 2019 13:28:17 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d67d2f1-1b42"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
comment_count.js
owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/plugins/disqus-comment-system/public/js/
889 B
691 B
Script
General
Full URL
https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/plugins/disqus-comment-system/public/js/comment_count.js?ver=3.0.17
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
cea0a05c5af6e21a409875328ed2e3dba79131b7c41f8ea07d0e0e02c7b7b59e

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:42 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5c99e3ee-379"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
local-storage-lib.js
owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/
1 KB
918 B
Script
General
Full URL
https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/local-storage-lib.js?ver=2.1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
693d39f8b27d78f2a570672b862512cb8e3dee72e8f641cf95ada2d81bac720b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:43 GMT
content-encoding
gzip
last-modified
Wed, 17 Jul 2019 13:03:16 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d2f1c94-591"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
npi-manager.js
owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/
3 KB
1 KB
Script
General
Full URL
https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/npi-manager.js?ver=2.1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
43a5ba666207ae3718ce7fe6b4015c58043b4ac4dfdacae285d5d8574d80fdf6

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:43 GMT
content-encoding
gzip
last-modified
Thu, 29 Aug 2019 13:28:17 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d67d2f1-b3b"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
hmi-registration-ui.manifest.js
s3.amazonaws.com/haymarket-reg-js/develop/production/
799 B
1 KB
Script
General
Full URL
https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.manifest.js?ver=0.1.1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.177.205 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
s3-1.amazonaws.com
Software
AmazonS3 /
Resource Hash
4d3e9dbf75d761b4fc344b3be601971eb517ce533c7ce46e093539e03349616e

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 20 Sep 2019 01:09:44 GMT
Last-Modified
Thu, 29 Aug 2019 20:10:10 GMT
Server
AmazonS3
x-amz-request-id
25E6E8835D95AA2C
ETag
"6878a8fbe72bde4a3f8ecf5b16523972"
Content-Type
application/javascript
x-amz-version-id
csLBKnYjTffo31CifRF6x383B2E_amuJ
Accept-Ranges
bytes
Content-Length
799
x-amz-id-2
6ARLVZVJc2nTnjQqCBIKgnqYe9T0ve8by7YtDb/Q8Hy5zZaLBIVV0yiDMzOhEpsYuT7Aa02EccI=
hmi-registration-ui.vendor.js
s3.amazonaws.com/haymarket-reg-js/develop/production/
357 KB
357 KB
Script
General
Full URL
https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?ver=0.1.1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.177.205 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
s3-1.amazonaws.com
Software
AmazonS3 /
Resource Hash
2673f6b0416b9a9f7488ee96f384f5badfa04acb14499c92ae52e394b7572f1f

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 20 Sep 2019 01:09:44 GMT
Last-Modified
Thu, 29 Aug 2019 20:10:10 GMT
Server
AmazonS3
x-amz-request-id
4EAF7F52E9DE15EE
ETag
"dfdfd93abc9eec4ff346a12a61df7c41"
Content-Type
application/javascript
x-amz-version-id
6ACuZZ4Fakkhaw3IL9mD952B0XZGZK4Q
Accept-Ranges
bytes
Content-Length
365119
x-amz-id-2
H07gVEqpAUE0eHuCbww0Bf2GJj9SfBukhBOrPcf+P4tNMenD3NQfLCx43/9Hyh1dz5CQIhGUF0Q=
hmi-registration-ui.bundle.js
s3.amazonaws.com/haymarket-reg-js/develop/production/
1 MB
1 MB
Script
General
Full URL
https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.bundle.js?ver=0.1.1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.177.205 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
s3-1.amazonaws.com
Software
AmazonS3 /
Resource Hash
4eef9cbbcb01ac2538e54c45514c0560e686abf17070adfba489fd1b3b86455a

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 20 Sep 2019 01:09:44 GMT
Last-Modified
Thu, 29 Aug 2019 20:10:10 GMT
Server
AmazonS3
x-amz-request-id
6AC56E193461E6FB
ETag
"8f47379688c3f5980d42b891fcaea0eb"
Content-Type
application/javascript
x-amz-version-id
1g9qbXhjK6v_p1EyiVTzg_c7stFBXUFD
Accept-Ranges
bytes
Content-Length
1225121
x-amz-id-2
yM2Z+J4bAziPaJ3nH0rEBlt29vFSUmPhiIwrKcuzALWV302l/2kF6XCksTP8/GmVlcBp5kWx2VU=
frontend.min.js
owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/
147 KB
39 KB
Script
General
Full URL
https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1568281912
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
be6beaacd90961241ca111e54c0953bc476a844a264e5afade4792a75c78c540

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:42 GMT
content-encoding
gzip
last-modified
Thu, 12 Sep 2019 09:51:52 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d7a1538-24c66"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
iab.min.js
owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/
8 KB
2 KB
Script
General
Full URL
https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1567085297
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
6463301e10c71f76fc14bb977dfa9097b5633ed4a3ee4119abccf2ead9aa9e29

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:42 GMT
content-encoding
gzip
last-modified
Thu, 29 Aug 2019 13:28:17 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d67d2f1-1ecd"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
wp-embed.min.js
owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-includes/js/
1 KB
1004 B
Script
General
Full URL
https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-includes/js/wp-embed.min.js?ver=5.2.3
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
2152557cac69e2bd7d6debef5037a9f554f9209cc305b8141b3329acb10c42b7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:42 GMT
content-encoding
gzip
last-modified
Thu, 30 Aug 2018 12:40:26 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5b87e5ba-57b"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
nativeai.js
cdn.native.ai/js/current/
130 KB
43 KB
Script
General
Full URL
https://cdn.native.ai/js/current/nativeai.js?1568851200000
Requested by
Host: owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com
URL: https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/plugins/hm-nativeai-tracker/js/hm-nativeai-tracking-tag.js?ver=1.0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.35.253.58 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-35-253-58.fra6.r.cloudfront.net
Software
nginx / ASP.NET
Resource Hash
bfcea73208d9a1f1a1f89d306cdff89c8d4a8740f0e7ab8b84501c1b86f3fd94

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 20 Sep 2019 01:09:43 GMT
Content-Encoding
gzip
Last-Modified
Fri, 12 Jul 2019 21:55:34 GMT
Server
nginx
X-Amz-Cf-Pop
FRA6-C1
X-Powered-By
ASP.NET
Vary
Accept-Encoding
X-Cache
RefreshHit from cloudfront
Content-Type
application/javascript
Via
1.1 d07eabeb1ed60c06da1457f35fb5c8c5.cloudfront.net (CloudFront)
Cache-Control
max-age=0,must-revalidate
Transfer-Encoding
chunked
Connection
keep-alive
X-Amz-Cf-Id
zJz1Tw6D4ZH3a1Nh4sBJjcgYy4OevTgLyK9Z33tClSIm3gPmcrdBPw==
integrator.js
adservice.google.de/adsid/
109 B
171 B
Script
General
Full URL
https://adservice.google.de/adsid/integrator.js?domain=www.clinicaladvisor.com
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:817::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 20 Sep 2019 01:09:42 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
104
x-xss-protection
0
integrator.js
adservice.google.com/adsid/
109 B
171 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.clinicaladvisor.com
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:817::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 20 Sep 2019 01:09:42 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
104
x-xss-protection
0
pubads_impl_2019091201.js
securepubads.g.doubleclick.net/gpt/
157 KB
58 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019091201.js
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.206.2 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s20-in-f2.1e100.net
Software
sffe /
Resource Hash
511c23178d504d371d22fb6899174f448db32523e9cacd2860306a2b3b8cc1f5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:43 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Thu, 12 Sep 2019 13:06:13 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
58953
x-xss-protection
0
expires
Fri, 20 Sep 2019 01:09:43 GMT
7341.js
script.crazyegg.com/pages/scripts/0034/
87 KB
28 KB
Script
General
Full URL
https://script.crazyegg.com/pages/scripts/0034/7341.js?435817
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-PXC3M3S
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6813:9408 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
0a2b71ee206e66ae16bd0904a7ecb5ae5288bd11ce6d963917e2ebc8ab1212d0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:43 GMT
via
1.1 a01b7aca64c6d4b437b814f64422d6c8.cloudfront.net (CloudFront)
cf-cache-status
HIT
age
9834
cf-polished
origSize=89183
x-cache
Hit from cloudfront
status
200
content-encoding
gzip
last-modified
Mon, 09 Sep 2019 13:24:04 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/x-javascript
cache-control
private, max-age=300
x-amz-cf-pop
VIE50-C1
cf-ray
518fea615c4fcba4-VIE
x-amz-cf-id
zfNKs8lzNGAD6Mqu3UzBcCq5ktPX28brugXoeRkrjC_aEvk0YwUELw==
cf-bgj
minify
analytics.js
www.google-analytics.com/
43 KB
17 KB
Script
General
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-PXC3M3S
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
dbb67c620eaabf6679a314db18d3ae43037aef71ab27422e6feec08ee987cc0a
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 19 Aug 2019 17:22:41 GMT
server
Golfe2
age
1570
date
Fri, 20 Sep 2019 00:43:33 GMT
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
public, max-age=7200
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
17803
expires
Fri, 20 Sep 2019 02:43:33 GMT
b2
sb.scorecardresearch.com/
Redirect Chain
  • https://sb.scorecardresearch.com/b?c1=2&c2=21948019&ns__t=1568941782904&ns_c=UTF-8&c8=FDA%20to%20Assess%20First%20Drug%20Meant%20to%20Prevent%20Peanut%20Allergy%20-%20Clinical%20Advisor&c7=https%3A...
  • https://sb.scorecardresearch.com/b2?c1=2&c2=21948019&ns__t=1568941782904&ns_c=UTF-8&c8=FDA%20to%20Assess%20First%20Drug%20Meant%20to%20Prevent%20Peanut%20Allergy%20-%20Clinical%20Advisor&c7=https%3...
0
248 B
Image
General
Full URL
https://sb.scorecardresearch.com/b2?c1=2&c2=21948019&ns__t=1568941782904&ns_c=UTF-8&c8=FDA%20to%20Assess%20First%20Drug%20Meant%20to%20Prevent%20Peanut%20Allergy%20-%20Clinical%20Advisor&c7=https%3A%2F%2Fwww.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&c9=
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.19.43.224 , Ascension Island, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a2-19-43-224.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 20 Sep 2019 01:09:43 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Length
0
Expires
Mon, 01 Jan 1990 00:00:00 GMT

Redirect headers

Location
https://sb.scorecardresearch.com/b2?c1=2&c2=21948019&ns__t=1568941782904&ns_c=UTF-8&c8=FDA%20to%20Assess%20First%20Drug%20Meant%20to%20Prevent%20Peanut%20Allergy%20-%20Clinical%20Advisor&c7=https%3A%2F%2Fwww.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&c9=
Pragma
no-cache
Date
Fri, 20 Sep 2019 01:09:43 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Length
0
Expires
Mon, 01 Jan 1990 00:00:00 GMT
src.svg
www.clinicaladvisor.com/wp-content/themes/haymarket/assets/svg/
33 KB
10 KB
Other
General
Full URL
https://www.clinicaladvisor.com/wp-content/themes/haymarket/assets/svg/src.svg?ver=1553589230
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
866e74600600f8647c979414828f3538d646101dc8504de84c2ed00e30460811

Request headers

Sec-Fetch-Mode
same-origin
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:43 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
nginx
status
200
etag
W/"5c99e3ee-8317"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
public, max-age=31536000
chevron-right-white.svg
owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/svg/src/
190 B
400 B
Image
General
Full URL
https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/svg/src/chevron-right-white.svg
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
8e0da2e2d764c1a202d33dd39287784df8ac6bc20c7401ea14f2d62001292856

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/style.min.css?ver=1567085297
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:43 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5c99e3ee-be"
vary
Accept-Encoding
x-cache
HIT
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
public, max-age=31536000
S6u9w4BMUTPHh6UVSwiPGQ3q5d0.woff2
fonts.gstatic.com/s/lato/v16/
14 KB
14 KB
Font
General
Full URL
https://fonts.gstatic.com/s/lato/v16/S6u9w4BMUTPHh6UVSwiPGQ3q5d0.woff2
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
9baad10e85c5be8d5697086479983b6b477197103bf8f0f11817b1bdfb9a7451
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Helvetica:400,400i,700,700i
Origin
https://www.clinicaladvisor.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 03 Sep 2019 19:34:39 GMT
x-content-type-options
nosniff
last-modified
Tue, 23 Jul 2019 03:45:54 GMT
server
sffe
age
1402504
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
14176
x-xss-protection
0
expires
Wed, 02 Sep 2020 19:34:39 GMT
S6uyw4BMUTPHjx4wXiWtFCc.woff2
fonts.gstatic.com/s/lato/v16/
14 KB
14 KB
Font
General
Full URL
https://fonts.gstatic.com/s/lato/v16/S6uyw4BMUTPHjx4wXiWtFCc.woff2
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
036d841b132c14046e26d8f2da1bc634c6ad34885ed1295660694a91c98933a6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Helvetica:400,400i,700,700i
Origin
https://www.clinicaladvisor.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 23 Aug 2019 19:26:23 GMT
x-content-type-options
nosniff
last-modified
Tue, 23 Jul 2019 03:45:55 GMT
server
sffe
age
2353400
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
14044
x-xss-protection
0
expires
Sat, 22 Aug 2020 19:26:23 GMT
S6u8w4BMUTPHjxsAXC-qNiXg7Q.woff2
fonts.gstatic.com/s/lato/v16/
15 KB
15 KB
Font
General
Full URL
https://fonts.gstatic.com/s/lato/v16/S6u8w4BMUTPHjxsAXC-qNiXg7Q.woff2
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
fe4bbdad1d6dff75cde79f8afc07f29502bd4708cb0ce5f552083c3d81ba8382
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Helvetica:400,400i,700,700i
Origin
https://www.clinicaladvisor.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 25 Aug 2019 03:27:53 GMT
x-content-type-options
nosniff
last-modified
Tue, 23 Jul 2019 03:45:51 GMT
server
sffe
age
2238110
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
14864
x-xss-protection
0
expires
Mon, 24 Aug 2020 03:27:53 GMT
font
fonts.gstatic.com/l/
12 KB
12 KB
Font
General
Full URL
https://fonts.gstatic.com/l/font?kit=JIAxUVNqfH9WuVQQRM4zVxOnPzMveA&skey=22efecd2bc0e2cb0&v=v3
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
932d9f9bda44020ec6b84128cca05dcf48c9925aa2db604c02acb31e187d1df8
Security Headers
Name Value
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Helvetica:400,400i,700,700i
Origin
https://www.clinicaladvisor.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Thu, 19 Sep 2019 05:44:51 GMT
last-modified
Mon, 29 Apr 2019 21:54:35 GMT
server
ESF
age
69892
status
200
x-frame-options
SAMEORIGIN
content-type
font/woff2
access-control-allow-origin
*
cache-control
private, max-age=86400
content-disposition
attachment; filename="font.woff2"; filename*=UTF-8''font.woff2
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
12485
x-xss-protection
0
expires
Thu, 19 Sep 2019 05:44:51 GMT
js
www.google-analytics.com/gtm/
58 KB
22 KB
Script
General
Full URL
https://www.google-analytics.com/gtm/js?id=GTM-WCJHGCK&t=gtm1&cid=719138576.1568941783
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
b1b808ff3998f3fbadbd909019ade8d7276aad27c31fb300e4ae977d9644d510
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:43 GMT
content-encoding
br
last-modified
Fri, 20 Sep 2019 00:00:00 GMT
server
Google Tag Manager
access-control-allow-headers
Cache-Control
status
200
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
http://www.googletagmanager.com
cache-control
private, max-age=900
access-control-allow-credentials
true
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
22096
x-xss-protection
0
expires
Fri, 20 Sep 2019 01:09:43 GMT
fbevents.js
connect.facebook.net/en_US/
121 KB
31 KB
Script
General
Full URL
https://connect.facebook.net/en_US/fbevents.js
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f02d:12:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
/
Resource Hash
14d88b3a27f0e6de034f86ad42d6411081e9467daf754147f2f16bcb20782177
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
content-length
31604
x-xss-protection
0
pragma
public
x-fb-debug
XnI4WECJUT+iIOW87GLhU6b1krnI4B1p/Mlk0t0v65mhXaZSMEcIjt167u0xzZf+wej1CzxgIoYrLGTn/EwSDQ==
x-fb-trip-id
420120009
x-frame-options
DENY
date
Fri, 20 Sep 2019 01:09:43 GMT
vary
Origin, Accept-Encoding
access-control-allow-methods
OPTIONS
content-type
application/x-javascript; charset=utf-8
access-control-allow-origin
https://connect.facebook.net
access-control-expose-headers
X-FB-Debug, X-Loader-Length
cache-control
public, max-age=1200
access-control-allow-credentials
true
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';
expires
Sat, 01 Jan 2000 00:00:00 GMT
gg.js
sb.scorecardresearch.com/rs/pt/
2 KB
1 KB
Script
General
Full URL
https://sb.scorecardresearch.com/rs/pt/gg.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-PXC3M3S
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.19.43.224 , Ascension Island, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a2-19-43-224.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
d0e90581c7b707bcad9f78f9b066371e6b1377d993ff03cbdee7193d6068ac78

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 20 Sep 2019 01:09:43 GMT
Content-Encoding
gzip
Connection
keep-alive
X-N
S
Content-Length
1246
Vary
Accept-Encoding
Content-Type
application/x-javascript
i
sp.sitomobile.com/
Redirect Chain
  • https://mt.sitomobile.com/sync/ta?aid=136&sid=hmm&val=4
  • https://pixel.tapad.com/idsync/ex/push?partner_id=2822&partner_url=https%3A%2F%2Fmt.sitomobile.com%2Fsync%2Ftacb%3Fexid%3D%24%7BTA_DEVICE_ID%7D%26aid%3D136%26sid%3Dhmm%26val%3D4
  • https://pixel.tapad.com/idsync/ex/push/check?partner_id=2822&partner_url=https%3A%2F%2Fmt.sitomobile.com%2Fsync%2Ftacb%3Fexid%3D%24%7BTA_DEVICE_ID%7D%26aid%3D136%26sid%3Dhmm%26val%3D4
  • https://mt.sitomobile.com/sync/tacb?exid=5440b791-db43-11e9-a060-0a88419facc3&aid=136&sid=hmm&val=4
  • https://sp.sitomobile.com/i?tna=sito&p=mob&e=ue&ue_px=eyJzY2hlbWEiOiJpZ2x1OmNvbS5zbm93cGxvd2FuYWx5dGljcy5zbm93cGxvdy91bnN0cnVjdF9ldmVudC9qc29uc2NoZW1hLzEtMC0wIiwiZGF0YSI6eyJzY2hlbWEiOiJpZ2x1OmNvbS5...
43 B
388 B
Script
General
Full URL
https://sp.sitomobile.com/i?tna=sito&p=mob&e=ue&ue_px=eyJzY2hlbWEiOiJpZ2x1OmNvbS5zbm93cGxvd2FuYWx5dGljcy5zbm93cGxvdy91bnN0cnVjdF9ldmVudC9qc29uc2NoZW1hLzEtMC0wIiwiZGF0YSI6eyJzY2hlbWEiOiJpZ2x1OmNvbS5zaXRvbW9iaWxlLnNub3dwbG93L2Nvb2tpZV9zeW5jL2pzb25zY2hlbWEvMS0wLTAiLCJkYXRhIjp7InBhcnRuZXJJZCI6InRhcGFkIn19fQ%3D%3D&cx=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
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.211.28.224 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-211-28-224.compute-1.amazonaws.com
Software
Apache-Coyote/1.1 /
Resource Hash
f4eef8263281c0b26486637831251059757bc3fdc4c3a48045a8ef8646b36e8f

Request headers

Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 20 Sep 2019 01:09:43 GMT
Server
Apache-Coyote/1.1
Connection
keep-alive
P3P
policyref="/w3c/p3p.xml", CP="NOI DSP COR NID PSA OUR IND COM NAV STA"
Content-Length
43
Content-Type
image/gif

Redirect headers

Date
Fri, 20 Sep 2019 01:09:43 GMT
Server
nginx/1.12.1
X-Powered-By
Express
Vary
Accept
Content-Type
text/plain; charset=utf-8
Location
https://sp.sitomobile.com/i?tna=sito&p=mob&e=ue&ue_px=eyJzY2hlbWEiOiJpZ2x1OmNvbS5zbm93cGxvd2FuYWx5dGljcy5zbm93cGxvdy91bnN0cnVjdF9ldmVudC9qc29uc2NoZW1hLzEtMC0wIiwiZGF0YSI6eyJzY2hlbWEiOiJpZ2x1OmNvbS5zaXRvbW9iaWxlLnNub3dwbG93L2Nvb2tpZV9zeW5jL2pzb25zY2hlbWEvMS0wLTAiLCJkYXRhIjp7InBhcnRuZXJJZCI6InRhcGFkIn19fQ%3D%3D&cx=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
Connection
keep-alive
Content-Length
972
up_loader.1.1.0.js
js.adsrvr.org/
6 KB
2 KB
Script
General
Full URL
https://js.adsrvr.org/up_loader.1.1.0.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-PXC3M3S
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.207.113 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-207-113.fra53.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
7e98e381189d908e1981b6e535bcdd7f3edceafdb0e7095f3e04292e8aac6a0c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Thu, 19 Sep 2019 19:04:48 GMT
Content-Encoding
gzip
Last-Modified
Wed, 17 Jul 2019 18:26:10 GMT
Server
AmazonS3
Age
102002
Vary
Accept-Encoding
X-Cache
Hit from cloudfront
Content-Type
application/x-javascript
Via
1.1 80d90c7955dda88e3912960ead8e99d6.cloudfront.net (CloudFront)
Connection
keep-alive
Transfer-Encoding
chunked
X-Amz-Cf-Pop
FRA53-C1
X-Amz-Cf-Id
5-BJIWQZL2bYNEUJTuLwpo4JYaPqeSzS1dMlgIYHoflbEBDeHLpVzw==
004d8e84d92b918c58eddfb8f83206a17a287497.js
mpct1.maropost.com/accounts/1323/websites/1/track/
4 KB
3 KB
Script
General
Full URL
https://mpct1.maropost.com/accounts/1323/websites/1/track/004d8e84d92b918c58eddfb8f83206a17a287497.js?contact_id=2332181&campaign_id=68670&title=FDA%20to%20Assess%20First%20Drug%20Meant%20to%20Prevent%20Peanut%20Allergy%20-%20Clinical%20Advisor&url=https%3A%2F%2Fclinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F&parent_url=&version=2&&&&funnel[0][name]=&funnel[0][status]=started&funnel[0][time_out]=40&
Requested by
Host: content.maropost.com
URL: https://content.maropost.com/uploads/1323/websites/1/004d8e84d92b918c58eddfb8f83206a17a287497-v2.js?ver=1.1
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.238.92.4 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
4.92.238.35.bc.googleusercontent.com
Software
nginx/1.14.0 + Phusion Passenger 5.3.4 / Phusion Passenger 5.3.4
Resource Hash
f25d87479ef787608488a6132dee1bd1928bddd6f05bb451d314d575c098bcaf
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 20 Sep 2019 01:09:43 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
X-Powered-By
Phusion Passenger 5.3.4
Transfer-Encoding
chunked
Status
200 OK
Connection
keep-alive
Vary
Accept-Encoding
X-XSS-Protection
1; mode=block
X-Request-Id
2a66c503-9630-4a13-a9cc-978946740507
X-Runtime
0.026139
Server
nginx/1.14.0 + Phusion Passenger 5.3.4
ETag
W/"98b68e658d49fdc34cfd377d0fafbdac"
X-Frame-Options
SAMEORIGIN
Content-Type
text/javascript; charset=utf-8
Cache-Control
max-age=0, private, must-revalidate
count.js
clinicaladvisor.disqus.com/
1 KB
1 KB
Script
General
Full URL
https://clinicaladvisor.disqus.com/count.js
Requested by
Host: owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com
URL: https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/plugins/disqus-comment-system/public/js/comment_count.js?ver=3.0.17
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.12.134 Frankfurt am Main, Germany, ASN54113 (FASTLY - Fastly, US),
Reverse DNS
Software
nginx /
Resource Hash
3487ef2baf0c08ba660a8a143cdeb8ebeec961eea04bccd7c49096b4eb26b875
Security Headers
Name Value
Strict-Transport-Security max-age=300; includeSubdomains
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 20 Sep 2019 01:09:49 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
Age
981338
P3P
CP="DSP IDC CUR ADM DELi STP NAV COM UNI INT PHY DEM"
Connection
keep-alive
Vary
Accept-Encoding
Content-Length
871
X-XSS-Protection
1; mode=block
Last-Modified
Wed, 04 Sep 2019 20:05:34 GMT
Server
nginx
ETag
"5d70190e-367"
Strict-Transport-Security
max-age=300; includeSubdomains
Content-Type
application/javascript; charset=utf-8
Cache-Control
public, max-age=300
Link
<https://disqus.com>; rel=preconnect, <https://c.disquscdn.com>; rel=preconnect
1073716492693685
connect.facebook.net/signals/config/
307 KB
78 KB
Script
General
Full URL
https://connect.facebook.net/signals/config/1073716492693685?v=2.9.4&r=stable
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f02d:12:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
/
Resource Hash
93c4a8cc5d4782ed85c9a7661ce68d1e7e7e6d4a91a57219f649f77564617460
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
content-length
79754
x-xss-protection
0
pragma
public
x-fb-debug
Qbp/x/cYBmo6MrpvtuJdJ8x5r29VErA9WS1JCiaV1chcxmEPbc9ZGpzhYyv9U0TGZrceB5/B2yNg85SpU4MS9g==
x-fb-trip-id
420120009
x-frame-options
DENY
date
Fri, 20 Sep 2019 01:09:43 GMT
vary
Origin, Accept-Encoding
access-control-allow-methods
OPTIONS
content-type
application/x-javascript; charset=utf-8
access-control-allow-origin
https://connect.facebook.net
access-control-expose-headers
X-FB-Debug, X-Loader-Length
cache-control
public, max-age=1200
access-control-allow-credentials
true
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
expires
Sat, 01 Jan 2000 00:00:00 GMT
lio.js
c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/
45 KB
11 KB
Script
General
Full URL
https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Requested by
Host: owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com
URL: https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1568281912
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
803e3ba42413340bcc0c185e1b5f40bfcc115ed3a52832ffcdf7827cbf239be0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
518fea620ed959f4-VIE
date
Fri, 20 Sep 2019 01:09:43 GMT
via
1.1 google
cf-cache-status
HIT
server
cloudflare
age
114
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=7200
content-encoding
br
expires
Fri, 20 Sep 2019 03:09:43 GMT
most-widget
www.clinicaladvisor.com/wp-json/haymarket/v1/
5 KB
2 KB
XHR
General
Full URL
https://www.clinicaladvisor.com/wp-json/haymarket/v1/most-widget?id=most-4
Requested by
Host: owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com
URL: https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1568281912
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
ed1d2b774300720920b1aa60faabf417f68fa7ef81c7ddb45f691edf90653d62
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:43 GMT
content-encoding
gzip
x-content-type-options
nosniff
x-cacheable
SHORT
x-cache
HIT: 4
status
200
x-wpengine-segment
NONHT
x-cache-group
normal
access-control-allow-headers
Authorization, Content-Type
allow
GET
server
nginx
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding,Cookie
content-type
application/json; charset=UTF-8
access-control-expose-headers
X-WP-Total, X-WP-TotalPages
cache-control
max-age=600, must-revalidate
x-distributor
yes
x-robots-tag
noindex
link
<https://www.clinicaladvisor.com/wp-json/>; rel="https://api.w.org/"
x-pass-why
partial-login
www.clinicaladvisor.com/wp-json/haymarket/v1/
644 B
845 B
XHR
General
Full URL
https://www.clinicaladvisor.com/wp-json/haymarket/v1/partial-login?subid=&subemail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1
Requested by
Host: owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com
URL: https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1568281912
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
185738a50a6174cc44b697ea3b2ff688594f225c84440de5af6677645b1f5495
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:43 GMT
content-encoding
gzip
x-content-type-options
nosniff
x-cacheable
SHORT
x-cache
HIT: 3
status
200
x-wpengine-segment
NONHT
x-cache-group
normal
access-control-allow-headers
Authorization, Content-Type
allow
GET
server
nginx
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding,Cookie
content-type
application/json; charset=UTF-8
access-control-expose-headers
X-WP-Total, X-WP-TotalPages
cache-control
max-age=600, must-revalidate
x-distributor
yes
x-robots-tag
noindex
link
<https://www.clinicaladvisor.com/wp-json/>; rel="https://api.w.org/"
x-pass-why
/
accounts.haymarketmedia.com/sso/check/
45 B
450 B
XHR
General
Full URL
https://accounts.haymarketmedia.com/sso/check/?gn=101
Requested by
Host: owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com
URL: https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1568281912
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.174.96.0 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-35-174-96-0.compute-1.amazonaws.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
916b46685de3064525220ba828d946e60ab332f5e65c62d7df5fe9877f9c54b2

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:43 GMT
x-aspnetmvc-version
4.0
server
Microsoft-IIS/8.5
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET
status
200
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.clinicaladvisor.com
cache-control
private
access-control-allow-credentials
true
content-length
45
linkid.js
www.google-analytics.com/plugins/ua/
2 KB
947 B
Script
General
Full URL
https://www.google-analytics.com/plugins/ua/linkid.js
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
92fca55833f48b4289ac8f1cedd48752b580fce4ec4b5d81670b8193d6e51b54
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 00:19:41 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Thu, 21 Apr 2016 03:17:22 GMT
server
sffe
age
3002
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
public, max-age=3600
accept-ranges
bytes
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
856
x-xss-protection
0
expires
Fri, 20 Sep 2019 01:19:41 GMT
beacon.js
www.medtargetsystem.com/javascript/
177 KB
52 KB
Script
General
Full URL
https://www.medtargetsystem.com/javascript/beacon.js?v2.5.12
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.1.219.33 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-1-219-33.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) /
Resource Hash
f8267ba048700e87665b20a24624b97dfc5d89b94ccd582419fec98573b20b07

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 20 Sep 2019 01:09:43 GMT
Content-Encoding
gzip
Last-Modified
Fri, 06 Sep 2019 19:16:29 GMT
Server
Apache/2.4.7 (Ubuntu)
ETag
"2c2db-591e746737d40-gzip"
Vary
X-Forwarded-Proto,Accept-Encoding
Content-Type
application/javascript
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
52826
tag.aspx
ml314.com/
26 KB
12 KB
Script
General
Full URL
https://ml314.com/tag.aspx?2082019
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.252.62.73 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-252-62-73.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
390a28be2ca4bcea5b71fe050295281a1a8fc99175690cdd62de378190400acb

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 20 Sep 2019 01:09:43 GMT
Content-Encoding
gzip
Last-Modified
Thu, 19 Sep 2019 15:32:09 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
application/javascript; charset=utf-8
Cache-Control
public, max-age=51745
Connection
keep-alive
Content-Length
11933
Expires
Fri, 20 Sep 2019 15:32:09 GMT
inferredEvents.js
connect.facebook.net/signals/plugins/
35 KB
10 KB
Script
General
Full URL
https://connect.facebook.net/signals/plugins/inferredEvents.js?v=2.9.4
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f02d:12:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
/
Resource Hash
b4e9e9bef19c34422f55a7fdb9d10c4db5e39cff24b8c98a0be0e09b2ee6ac2b
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
content-length
10218
x-xss-protection
0
pragma
public
x-fb-debug
3fz6AVXEn0k6hoXYQKlkxJTKlbMA8cWIHnWnNA7wnVtqPpgmeiVB1S3lN70YGvWY4I3kadGot+0JREbjpEFFZg==
x-fb-trip-id
420120009
x-frame-options
DENY
date
Fri, 20 Sep 2019 01:09:43 GMT
vary
Accept-Encoding
content-type
application/x-javascript; charset=utf-8
cache-control
public, max-age=1200
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';
expires
Sat, 01 Jan 2000 00:00:00 GMT
io.min.js
c.lytics.io/static/v2/
13 KB
6 KB
Script
General
Full URL
https://c.lytics.io/static/v2/io.min.js
Requested by
Host: c.lytics.io
URL: https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
1c0e0ca6ba3ee267ba14d39184efb68c958717fc6e58b528b700502c0aea5170

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
518fea625ee859f4-VIE
date
Fri, 20 Sep 2019 01:09:43 GMT
via
1.1 google
cf-cache-status
HIT
last-modified
Fri, 13 Sep 2019 19:02:47 GMT
server
cloudflare
age
2752
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=7200
content-encoding
br
expires
Fri, 20 Sep 2019 03:09:43 GMT
ga-audiences
www.google.de/ads/
Redirect Chain
  • https://www.google-analytics.com/r/collect?v=1&_v=j79&a=1445100269&t=pageview&_s=1&dl=https%3A%2F%2Fwww.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-asse...
  • https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-1290429-4&cid=719138576.1568941783&jid=2109231193&_gid=201143169.1568941783&gjid=1228871920&_v=j79&z=1855722087
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-4&cid=719138576.1568941783&jid=2109231193&_v=j79&z=1855722087
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-4&cid=719138576.1568941783&jid=2109231193&_v=j79&z=1855722087&slf_rd=1&random=3883267600
42 B
109 B
Image
General
Full URL
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-4&cid=719138576.1568941783&jid=2109231193&_v=j79&z=1855722087&slf_rd=1&random=3883267600
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81c::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:43 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, no-store, must-revalidate
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:43 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
302
content-type
text/html; charset=UTF-8
location
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-4&cid=719138576.1568941783&jid=2109231193&_v=j79&z=1855722087&slf_rd=1&random=3883267600
cache-control
no-cache, no-store, must-revalidate
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
www.facebook.com/tr/
44 B
247 B
Image
General
Full URL
https://www.facebook.com/tr/?id=1073716492693685&ev=PageView&dl=https%3A%2F%2Fwww.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&rl=&if=false&ts=1568941783418&sw=1600&sh=1200&v=2.9.4&r=stable&ec=0&o=30&fbp=fb.1.1568941783417.561361708&it=1568941783356&coo=false&rqm=GET
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f12d:83:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:43 GMT
last-modified
Fri, 21 Dec 2012 00:00:01 GMT
server
proxygen-bolt
strict-transport-security
max-age=31536000; includeSubDomains
content-type
image/gif
status
200
cache-control
no-cache, must-revalidate, max-age=0
content-length
44
expires
Fri, 20 Sep 2019 01:09:43 GMT
utsync.ashx
ml314.com/
793 B
2 KB
Script
General
Full URL
https://ml314.com/utsync.ashx?pub=&adv=&et=0&eid=740&ct=js&pi=&fp=&clid=&if=0&ps=&cl=&mlt=&data=&&cp=https%3A%2F%2Fwww.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&pv=1568941783425_000tzn489&bl=en-us&cb=4649360&return=&ht=&d=&dc=&si=1568941783425_000tzn489&cid=&s=1600x1200&rp=
Requested by
Host: ml314.com
URL: https://ml314.com/tag.aspx?2082019
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.252.62.73 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-252-62-73.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
338d14a6afb3d92427678ab5d2232bec84d5e35ce853747d1e2d771905934597

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 20 Sep 2019 01:09:43 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
p3P
CP="NON DSP COR ADMo PSAo DEVo BUS COM UNI NAV DEM STA"
Cache-Control
private
Connection
keep-alive
Content-Type
application/javascript; charset=utf-8
Content-Length
486
Expires
0
ud.ashx
in.ml314.com/
20 B
698 B
Script
General
Full URL
https://in.ml314.com/ud.ashx?topiclimit=&cb=2082019
Requested by
Host: ml314.com
URL: https://ml314.com/tag.aspx?2082019
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.233.109.111 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-233-109-111.compute-1.amazonaws.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
d0e4a6372d6fb5ffe9505dbe9e94aee8f1b9b96ec8e5e20684cce8b4c5a88fa7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 20 Sep 2019 01:09:43 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/8.5
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
application/javascript; charset=utf-8
Cache-Control
public, no-cache="set-cookie"
Connection
keep-alive
Content-Length
138
Expires
Sat, 21 Sep 2019 01:09:43 GMT
4
c.lytics.io/cid/
78 B
204 B
Script
General
Full URL
https://c.lytics.io/cid/4?callback=jQuery1124020157873618934508_1568941782830&_=1568941782831
Requested by
Host: owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com
URL: https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-includes/js/jquery/jquery.js?ver=1.12.4-wp
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
63257693f4fd14c93db61acada138a99f01403e4d4a563c3f465cfe1b67d708b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
518fea629eee59f4-VIE
pragma
no-cache
date
Fri, 20 Sep 2019 01:09:43 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
text/javascript
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
content-encoding
br
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
expires
0
csync.ashx
ml314.com/
Redirect Chain
  • https://tags.bluekai.com/site/20486?limit=0&id=5978151499129049387&redir=https://ml314.com/csync.ashx%3Ffp=$_BK_UUID%26person_id=5978151499129049387%26eid=50056
  • https://ml314.com/csync.ashx?fp=q48tmQ9999eH5GH5&person_id=5978151499129049387&eid=50056
43 B
312 B
Image
General
Full URL
https://ml314.com/csync.ashx?fp=q48tmQ9999eH5GH5&person_id=5978151499129049387&eid=50056
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.252.62.73 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-252-62-73.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 20 Sep 2019 01:09:43 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
image/gif
Cache-Control
private
Connection
keep-alive
Content-Length
43
Expires
Fri, 20 Sep 2019 21:09:43 GMT

Redirect headers

Location
https://ml314.com/csync.ashx?fp=q48tmQ9999eH5GH5&person_id=5978151499129049387&eid=50056
Date
Fri, 20 Sep 2019 01:09:43 GMT
Connection
keep-alive
Content-Length
0
BK-Server
be52
P3P
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV", policyref="http://tags.bluekai.com/w3c/p3p.xml"
csync.ashx
ml314.com/
Redirect Chain
  • https://idsync.rlcdn.com/395886.gif?partner_uid=5978151499129049387
  • https://idsync.rlcdn.com/1000.gif?memo=CO6UGBIeChoIARCuXxoTNTk3ODE1MTQ5OTEyOTA0OTM4NxAAGg0I182Q7AUSBQjoBxAAQgBKAA
  • https://ml314.com/csync.ashx?fp=&person_id=5978151499129049387&eid=50082
43 B
312 B
Image
General
Full URL
https://ml314.com/csync.ashx?fp=&person_id=5978151499129049387&eid=50082
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.252.62.73 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-252-62-73.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 20 Sep 2019 01:09:42 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
image/gif
Cache-Control
private
Connection
keep-alive
Content-Length
43
Expires
Fri, 20 Sep 2019 21:09:43 GMT

Redirect headers

date
Fri, 20 Sep 2019 01:09:43 GMT
via
1.1 google
status
307
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
location
https://ml314.com/csync.ashx?fp=&person_id=5978151499129049387&eid=50082
cache-control
no-cache, no-store
timing-allow-origin
*
alt-svc
clear
content-length
0
csync.ashx
ml314.com/
Redirect Chain
  • https://pixel.mathtag.com/sync/img?redir=https://ml314.com/csync.ashx%3Ffp=[MM_UUID]%26person_id=5978151499129049387%26eid=50220
  • https://pixel.mathtag.com/sync/img?redir=https://ml314.com/csync.ashx%3Ffp=[MM_UUID]%26person_id=5978151499129049387%26eid=50220&mm_bnc&mm_bct&UUID=16575d84-16e8-4600-89b1-cff494536fe4
  • https://ml314.com/csync.ashx?fp=16575d84-16e8-4600-89b1-cff494536fe4&person_id=5978151499129049387&eid=50220
43 B
312 B
Image
General
Full URL
https://ml314.com/csync.ashx?fp=16575d84-16e8-4600-89b1-cff494536fe4&person_id=5978151499129049387&eid=50220
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.252.62.73 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-252-62-73.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 20 Sep 2019 01:09:42 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
image/gif
Cache-Control
private
Connection
keep-alive
Content-Length
43
Expires
Fri, 20 Sep 2019 21:09:43 GMT

Redirect headers

Date
Fri, 20 Sep 2019 01:09:43 GMT
Server
MT3 1734 ed2a032 master cdg-pixel-x23
P3P
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
Location
https://ml314.com/csync.ashx?fp=16575d84-16e8-4600-89b1-cff494536fe4&person_id=5978151499129049387&eid=50220
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
0
Expires
Fri, 20 Sep 2019 01:09:42 GMT
csync.ashx
ml314.com/
Redirect Chain
  • https://sync.crwdcntrl.net/map/c=6985/tp=BOMB?https://ml314.com/csync.ashx%3Ffp%3D%24%7Bprofile_id%7D%26eid%3D50146%26person_id%3D5978151499129049387
  • https://sync.crwdcntrl.net/map/ct=y/c=6985/tp=BOMB?https://ml314.com/csync.ashx%3Ffp%3D%24%7Bprofile_id%7D%26eid%3D50146%26person_id%3D5978151499129049387
  • https://ml314.com/csync.ashx?fp=31a2d085fe5b6cb16bdbff102dc4eaab&eid=50146&person_id=5978151499129049387
43 B
312 B
Image
General
Full URL
https://ml314.com/csync.ashx?fp=31a2d085fe5b6cb16bdbff102dc4eaab&eid=50146&person_id=5978151499129049387
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.252.62.73 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-252-62-73.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 20 Sep 2019 01:09:42 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
image/gif
Cache-Control
private
Connection
keep-alive
Content-Length
43
Expires
Fri, 20 Sep 2019 21:09:43 GMT

Redirect headers

Pragma
no-cache
Date
Fri, 20 Sep 2019 01:09:43 GMT
P3P
CP=NOI DSP COR NID PSAa PSDa OUR UNI COM NAV
Location
https://ml314.com/csync.ashx?fp=31a2d085fe5b6cb16bdbff102dc4eaab&eid=50146&person_id=5978151499129049387
Cache-Control
no-cache
X-Server
10.45.24.123
Connection
keep-alive
Content-Length
0
Expires
0
match
ps.eyeota.net/
Redirect Chain
  • https://ps.eyeota.net/pixel?pid=r8hrb20&t=gif
  • https://ps.eyeota.net/pixel/bounce/?pid=r8hrb20&t=gif
  • https://ml314.com/utsync.ashx?eid=50052&et=0&fp=2fcdtmnSd5DdgXN9bsE4uhqBsLq2UvAScb1MqGdAZAYU&gdpr=1&gdpr_consent=&return=https%3A%2F%2Fps.eyeota.net%2Fmatch%3Fbid%3Dr8hrb20%26uid%3Dnil
  • https://ml314.com/csync.ashx?fp=2fcdtmnSd5DdgXN9bsE4uhqBsLq2UvAScb1MqGdAZAYU&person_id=5978151499129049387&eid=50052&return=https%3a%2f%2fps.eyeota.net%2fmatch%3fbid%3dr8hrb20%26uid%3dnil
  • https://ps.eyeota.net/match?bid=r8hrb20&uid=nil
70 B
171 B
Image
General
Full URL
https://ps.eyeota.net/match?bid=r8hrb20&uid=nil
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
18.195.52.121 Frankfurt am Main, Germany, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-18-195-52-121.eu-central-1.compute.amazonaws.com
Software
/
Resource Hash
de9d3fd0eb948bd294477d0eda60a73b85caff1794803530d0463193a113da98

Request headers

Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 20 Sep 2019 01:09:43 GMT
Content-Length
70
Content-Type
image/gif

Redirect headers

Date
Fri, 20 Sep 2019 01:09:42 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
text/html; charset=utf-8
Location
https://ps.eyeota.net/match?bid=r8hrb20&uid=nil
Cache-Control
private
Connection
keep-alive
Content-Length
168
Expires
Fri, 20 Sep 2019 21:09:43 GMT
4d17370bde885f6acda1f3268cfe6917
api.lytics.io/api/me/iframe/43bffbce6f25564c8e2145a11836ff9f/_uid/ Frame 8BE8
0
0
Document
General
Full URL
https://api.lytics.io/api/me/iframe/43bffbce6f25564c8e2145a11836ff9f/_uid/4d17370bde885f6acda1f3268cfe6917?segments=true&mergestate=true&ts=1568941783595
Requested by
Host: c.lytics.io
URL: https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.227.192.113 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
113.192.227.35.bc.googleusercontent.com
Software
lytics.io 12010e506c8dcbc0f3f8eab734c1f26422f84c6c /
Resource Hash

Request headers

:method
GET
:authority
api.lytics.io
:scheme
https
:path
/api/me/iframe/43bffbce6f25564c8e2145a11836ff9f/_uid/4d17370bde885f6acda1f3268cfe6917?segments=true&mergestate=true&ts=1568941783595
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
accept-encoding
gzip, deflate, br
cookie
__cfduid=d4e7275e157f4e2acb29de790efff52851568941783; seerid=4d17370bde885f6acda1f3268cfe6917
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181

Response headers

status
200
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Authorization, Cookie, *
access-control-allow-methods
GET
access-control-allow-origin
content-encoding
gzip
content-type
text/html
server
lytics.io 12010e506c8dcbc0f3f8eab734c1f26422f84c6c
date
Fri, 20 Sep 2019 01:09:43 GMT
content-length
294
via
1.1 google
alt-svc
clear
/
www.facebook.com/tr/ Frame 3219
0
0
Document
General
Full URL
https://www.facebook.com/tr/
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f12d:83:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

:method
POST
:authority
www.facebook.com
:scheme
https
:path
/tr/
content-length
12880
pragma
no-cache
cache-control
no-cache
origin
https://www.clinicaladvisor.com
upgrade-insecure-requests
1
content-type
application/x-www-form-urlencoded
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
accept-encoding
gzip, deflate, br
cookie
fr=0LglEpatKWWoOpHPI..BdhCbX...1.0.BdhCbX.
Origin
https://www.clinicaladvisor.com
Upgrade-Insecure-Requests
1
Content-Type
application/x-www-form-urlencoded
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181

Response headers

status
200
content-type
text/plain
access-control-allow-origin
https://www.clinicaladvisor.com
access-control-allow-credentials
true
strict-transport-security
max-age=31536000; includeSubDomains
content-length
0
server
proxygen-bolt
date
Fri, 20 Sep 2019 01:09:43 GMT
Cookie set /
www.medtargetsystem.com/beacon/portal/ Frame F960
0
0
Document
General
Full URL
https://www.medtargetsystem.com/beacon/portal/?_url=https%3A%2F%2Fwww.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F&_sid=b708509b-3740-422b-a487-851422be3d93&_vid=ec41240c-8c9e-4a22-a70c-c578fadded2e&_ak=35-213-196850D0&_flash=false&_th=1568941783|1568941783|1
Requested by
Host: www.medtargetsystem.com
URL: https://www.medtargetsystem.com/javascript/beacon.js?v2.5.12
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.1.219.33 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-1-219-33.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) / PHP/7.0.19-1+deb.sury.org~trusty+2
Resource Hash

Request headers

Host
www.medtargetsystem.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
Sec-Fetch-Site
cross-site
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Accept-Encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181

Response headers

Cache-Control
no-store, no-cache, must-revalidate
Content-Encoding
gzip
Content-Type
text/html; charset=UTF-8
Date
Fri, 20 Sep 2019 01:09:44 GMT
Expires
Thu, 19 Nov 1981 08:52:00 GMT
P3P
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
Pragma
no-cache
Server
Apache/2.4.7 (Ubuntu)
Set-Cookie
DMDSESSID=akuki4odae498r475f04qpu957; path=/; HttpOnly
Vary
X-Forwarded-Proto,Accept-Encoding
X-Powered-By
PHP/7.0.19-1+deb.sury.org~trusty+2
Content-Length
6990
Connection
keep-alive
collect.gif
www.medtargetsystem.com/analytics/
0
313 B
Image
General
Full URL
https://www.medtargetsystem.com/analytics/collect.gif?e=1&aid=&vid=ec41240c-8c9e-4a22-a70c-c578fadded2e&sid=b708509b-3740-422b-a487-851422be3d93&vh=1&vt=1568941783&pt=1568941783&u=https%3A%2F%2Fwww.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&r=&t=FDA%20to%20Assess%20First%20Drug%20Meant%20to%20Prevent%20Peanut%20Allergy%20-%20Clinical%20Advisor&p=1824.08&pm=&ab=&ak=35-213-196850D0
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.1.219.33 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-1-219-33.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) / PHP/7.0.19-1+deb.sury.org~trusty+2
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 20 Sep 2019 01:09:44 GMT
Server
Apache/2.4.7 (Ubuntu)
Connection
keep-alive
X-Powered-By
PHP/7.0.19-1+deb.sury.org~trusty+2
Content-Length
0
Vary
X-Forwarded-Proto
Content-Type
text/html; charset=UTF-8
/
www.facebook.com/tr/ Frame 9A1B
0
0
Document
General
Full URL
https://www.facebook.com/tr/
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f12d:83:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

:method
POST
:authority
www.facebook.com
:scheme
https
:path
/tr/
content-length
3940
pragma
no-cache
cache-control
no-cache
origin
https://www.clinicaladvisor.com
upgrade-insecure-requests
1
content-type
application/x-www-form-urlencoded
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
accept-encoding
gzip, deflate, br
cookie
fr=0LglEpatKWWoOpHPI..BdhCbX...1.0.BdhCbX.
Origin
https://www.clinicaladvisor.com
Upgrade-Insecure-Requests
1
Content-Type
application/x-www-form-urlencoded
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181

Response headers

status
200
content-type
text/plain
access-control-allow-origin
https://www.clinicaladvisor.com
access-control-allow-credentials
true
strict-transport-security
max-age=31536000; includeSubDomains
content-length
0
server
proxygen-bolt
date
Fri, 20 Sep 2019 01:09:44 GMT
pathfora.min.js
c.lytics.io/static/
98 KB
20 KB
Script
General
Full URL
https://c.lytics.io/static/pathfora.min.js
Requested by
Host: c.lytics.io
URL: https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
4215e6200c04a4874f3d23c78af23fcd22b5bc3bc916237fd95c108aaae38735

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
518fea669f6359f4-VIE
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
cf-cache-status
HIT
last-modified
Wed, 03 Jul 2019 23:03:58 GMT
server
cloudflare
age
2449
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=7200
content-encoding
br
expires
Fri, 20 Sep 2019 03:09:44 GMT
43bffbce6f25564c8e2145a11836ff9f
c.lytics.io/c/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f?_ts=1568941784066&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_e=pv&utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&_sesstart=1&_tz=2&_ul=en-US&_sz=1600x1200&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea669f6459f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
43bffbce6f25564c8e2145a11836ff9f
c.lytics.io/c/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f?publicationId=6&channel=home&pagetype=post&tags=allergy%20%26amp%3B%20immunology&categories=allergy%20and%20immunology%20information%20center%2Cnews&pagename=FDA%20to%20Assess%20First%20Drug%20Meant%20to%20Prevent%20Peanut%20Allergy&author=&section=home%3Atopics%3Aallergy%20and%20immunology%20information%20center%3Afda%20to%20assess%20first%20drug%20meant%20to%20prevent%20peanut%20allergy&email=mathisc%40sutterhealth.org&user_id=0&cpn=obgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019&login=mathisc%40sutterhealth.org&userstate=CA&userspecialty=&userprofession=Physician&_ts=1568941784067&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea669f6559f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?gtm.start=1568941782752&event=gtm.js&gtm.uniqueEventId=4&_ts=1568941784067&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea669f6659f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.AdBlocking=&_ts=1568941784067&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea669f6759f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
104 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.NHTFlag=false&_ts=1568941784068&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea669f6859f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.ArticleId=94006%3A0&_ts=1568941784068&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea66bf6d59f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
101 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.ArticleType=Healthday&_ts=1568941784068&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea678f8d59f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.MetaData=&_ts=1568941784069&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea678f8e59f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Type=post&_ts=1568941784069&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea678f8f59f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.ScrollDepth=&_ts=1568941784069&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea678f9059f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.cmeActivityId=&_ts=1568941784070&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea678f9159f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.PrintSource=&_ts=1568941784070&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea679f9a59f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.SEOScore=&_ts=1568941784070&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea685fd059f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
165 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Site.Prefix=omn&_ts=1568941784070&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea686fd259f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
101 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Site.PublicationId=6&_ts=1568941784070&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea686fd559f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Author=&_ts=1568941784071&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea687fd859f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Novo.PremiumMonograph=&_ts=1568941784071&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea687fda59f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Novo.Geolocation=&_ts=1568941784071&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea688fdd59f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Activity.Name=&_ts=1568941784071&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea693ff859f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.GenericEvents=&_ts=1568941784071&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea693ffa59f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
231 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?eComm.CurrencyCode=&_ts=1568941784072&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea694ffc59f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?eComm.OrderId=&_ts=1568941784072&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea695ffd59f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Drug.CompanyName=&_ts=1568941784072&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea69680259f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Novo.IsPremiumMonograph=false&_ts=1568941784072&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea69680359f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.GatingType=post%3Anone&_ts=1568941784072&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6a183559f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Company=&_ts=1568941784073&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6a183759f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Discipline=&_ts=1568941784073&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6a383a59f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Asset=&_ts=1568941784073&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6a483e59f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.PublishDate=2019-09-17&_ts=1568941784073&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6a483f59f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Curation=false&_ts=1568941784074&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6a484659f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.WordCount=231&_ts=1568941784074&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6b087159f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?MyCME.CreditType=&_ts=1568941784074&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6b087259f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?MyCME.ActivityResult=&_ts=1568941784074&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6b187659f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.NumberofAdCalls=11&_ts=1568941784075&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6b287959f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?eComm.ProductsInCart=&_ts=1568941784075&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6b387d59f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Section1=home&_ts=1568941784075&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6b387e59f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Section2=home%3Atopics&_ts=1568941784075&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:45 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6bf8aa59f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
116 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Section3=home%3Atopics%3Aallergy%20and%20immunology%20information%20center&_ts=1568941784075&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:45 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6bf8ab59f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Section4=home%3Atopics%3Aallergy%20and%20immunology%20information%20center%3Afda%20to%20assess%20first%20drug%20meant%20to%20prevent%20peanut%20allergy&_ts=1568941784076&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:45 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6c08af59f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Tags=allergy%20%26amp%3B%20immunology&_ts=1568941784076&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:45 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6c18bb59f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Categories=allergy%20and%20immunology%20information%20center%2Cnews&_ts=1568941784076&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:45 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6c18bc59f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.LoggedIn=false&_ts=1568941784076&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:45 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6c28bd59f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Login=&_ts=1568941784077&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:45 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6cd8df59f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SocSSN=&_ts=1568941784077&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:45 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6ce8e559f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SSO=3&_ts=1568941784077&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:45 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6ce8e959f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SubscriberId=0&_ts=1568941784077&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:45 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6d08ec59f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Source=&_ts=1568941784077&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:45 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6d08ed59f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Profession=Physician&_ts=1568941784078&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:45 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6d08f459f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Specialty=&_ts=1568941784078&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:45 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6db92659f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SubProfession=&_ts=1568941784078&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:45 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6dc92a59f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SubSpecialty=&_ts=1568941784078&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:45 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6dd92e59f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.JobTitle=&_ts=1568941784079&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:45 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6dd93759f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.CampaignCodes=obgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019&_ts=1568941784079&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:45 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6de93d59f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Country=&_ts=1568941784079&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:45 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6df94459f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
95 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Company=&_ts=1568941784079&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:45 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6e997759f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
94 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.CompanySize=&_ts=1568941784079&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:45 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6ea97959f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
95 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.IsHaymarket=false&_ts=1568941784080&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:45 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6ec97c59f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.IsTracked=true&_ts=1568941784080&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:45 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6ec97e59f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
104 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.IsFromAim=false&_ts=1568941784080&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:45 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6ed98059f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
102 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.NpiNumber=1457423279&_ts=1568941784080&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:45 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6ed98559f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
236 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?gtm.start=1568941783298&event=gtm.js&gtm.uniqueEventId=3&_ts=1568941784080&_nmob=t&_device=desktop&url=www.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&_uid=4d17370bde885f6acda1f3268cfe6917&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:45 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
518fea6f89a659f4-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
4d17370bde885f6acda1f3268cfe6917
api.lytics.io/api/content/recommend/43bffbce6f25564c8e2145a11836ff9f/user/_uid/
216 KB
34 KB
XHR
General
Full URL
https://api.lytics.io/api/content/recommend/43bffbce6f25564c8e2145a11836ff9f/user/_uid/4d17370bde885f6acda1f3268cfe6917?limit=30&contentsegment=ca_content_collection&shuffle=true
Requested by
Host: owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com
URL: https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1568281912
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.227.192.113 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
113.192.227.35.bc.googleusercontent.com
Software
lytics.io 12010e506c8dcbc0f3f8eab734c1f26422f84c6c /
Resource Hash
eac60448c8320956aae3a6e52e1c92f6cdedb4f319688ed256f33ea44c1dab18

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:44 GMT
content-encoding
gzip
server
lytics.io 12010e506c8dcbc0f3f8eab734c1f26422f84c6c
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Authorization, Cookie, *
status
200
access-control-allow-methods
GET
content-type
application/json
access-control-allow-origin
https://www.clinicaladvisor.com
alt-svc
clear
via
1.1 google
pathfora.min.css
c.lytics.io/static/
20 KB
3 KB
Stylesheet
General
Full URL
https://c.lytics.io/static/pathfora.min.css
Requested by
Host: c.lytics.io
URL: https://c.lytics.io/static/pathfora.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
58aa5964d6f5dc68b2180e943ea63b6031c0ba83e44d9815e724b10f2f615f9f

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
518fea66cf6e59f4-VIE
date
Fri, 20 Sep 2019 01:09:44 GMT
via
1.1 google
cf-cache-status
HIT
last-modified
Wed, 03 Jul 2019 23:03:58 GMT
server
cloudflare
age
2581
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/css; charset=utf-8
status
200
cache-control
public, max-age=7200
content-encoding
br
expires
Fri, 20 Sep 2019 03:09:44 GMT
config.js
c.lytics.io/api/program/campaign/config/43bffbce6f25564c8e2145a11836ff9f/
85 KB
10 KB
Script
General
Full URL
https://c.lytics.io/api/program/campaign/config/43bffbce6f25564c8e2145a11836ff9f/config.js
Requested by
Host: c.lytics.io
URL: https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
06a096554c52051011d68d3e9dad453e681cd6a50e8be45ea95582ddcfe411c6

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
518fea6f99ab59f4-VIE
date
Fri, 20 Sep 2019 01:09:45 GMT
via
1.1 google
cf-cache-status
HIT
server
cloudflare
age
114
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=7200
content-encoding
br
expires
Fri, 20 Sep 2019 03:09:45 GMT
css
fonts.googleapis.com/
1 KB
488 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Lato:400,900
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.bundle.js?ver=0.1.1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:809::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
4bd7ab38b940371c161b19f0cf34bdfdeaac480eda86b13c29591ed01ed67c36
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Fri, 20 Sep 2019 01:09:44 GMT
server
ESF
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
status
200
date
Fri, 20 Sep 2019 01:09:44 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
x-xss-protection
0
expires
Fri, 20 Sep 2019 01:09:44 GMT
6
subapi.haymarketmedia.com/newsletterasset/
1 KB
2 KB
XHR
General
Full URL
https://subapi.haymarketmedia.com/newsletterasset/6
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?ver=0.1.1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.172.78.117 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-35-172-78-117.compute-1.amazonaws.com
Software
/ Express
Resource Hash
7126bf7fc5466468d3cc8600d68e0a397416cfad3ef4b59598102effccb72119

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

date
Fri, 20 Sep 2019 01:09:44 GMT
x-powered-by
Express
etag
W/"4e7-XKnDWdDmUiwxAm3AEbLvdi5mYe0"
status
200
access-control-allow-methods
GET, POST, OPTIONS
content-type
text/html; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
1255
truncated
/
24 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
65f72bc49f7e243cf332df6eb265d987e4c6e997e7aecd813ceace591f805071

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/gif
truncated
/
5 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
d9593473fc4d73446eac1a620bb1bbe590fc80d61d8909484dfee64ae522b787

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
6
subapi.haymarketmedia.com/newsletter/
1 KB
2 KB
XHR
General
Full URL
https://subapi.haymarketmedia.com/newsletter/6
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?ver=0.1.1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.172.78.117 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-35-172-78-117.compute-1.amazonaws.com
Software
/ Express
Resource Hash
7126bf7fc5466468d3cc8600d68e0a397416cfad3ef4b59598102effccb72119

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

date
Fri, 20 Sep 2019 01:09:44 GMT
x-powered-by
Express
etag
W/"4e7-XKnDWdDmUiwxAm3AEbLvdi5mYe0"
status
200
access-control-allow-methods
GET, POST, OPTIONS
content-type
text/html; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
1255
6
subapi.haymarketmedia.com/newsletter/
1 KB
2 KB
XHR
General
Full URL
https://subapi.haymarketmedia.com/newsletter/6
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?ver=0.1.1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.172.78.117 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-35-172-78-117.compute-1.amazonaws.com
Software
/ Express
Resource Hash
7126bf7fc5466468d3cc8600d68e0a397416cfad3ef4b59598102effccb72119

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

date
Fri, 20 Sep 2019 01:09:44 GMT
x-powered-by
Express
etag
W/"4e7-XKnDWdDmUiwxAm3AEbLvdi5mYe0"
status
200
access-control-allow-methods
GET, POST, OPTIONS
content-type
text/html; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
1255
collect.gif
www.medtargetsystem.com/analytics/
0
245 B
Image
General
Full URL
https://www.medtargetsystem.com/analytics/collect.gif?e=1&aid=&vid=ec41240c-8c9e-4a22-a70c-c578fadded2e&sid=b708509b-3740-422b-a487-851422be3d93&vh=2&vt=1568941783&pt=1568941784&u=https%3A%2F%2Fwww.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&r=&t=FDA%20to%20Assess%20First%20Drug%20Meant%20to%20Prevent%20Peanut%20Allergy%20-%20Clinical%20Advisor&p=2150.47&pm=&ab=&ak=35-213-196850D0
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.1.219.33 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-1-219-33.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) / PHP/7.0.19-1+deb.sury.org~trusty+2
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 20 Sep 2019 01:09:44 GMT
Server
Apache/2.4.7 (Ubuntu)
Connection
keep-alive
X-Powered-By
PHP/7.0.19-1+deb.sury.org~trusty+2
Content-Length
0
Vary
X-Forwarded-Proto
Content-Type
text/html; charset=UTF-8
truncated
/
82 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
ad9d820f1802abd0f80d4e260c43cd6c92d643c926732a00296821182ae3f9c7

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/svg+xml
font
fonts.gstatic.com/l/
12 KB
12 KB
Font
General
Full URL
https://fonts.gstatic.com/l/font?kit=JIA0UVNqfH9WuVQQRM477DayEhEiUjZ7XQ&skey=c9794b4fcbed8443&v=v3
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
545431e9ab393bd135f7eae063d9e8298b2c9252aee383003ec78944cd8a71cd
Security Headers
Name Value
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Helvetica:400,400i,700,700i
Origin
https://www.clinicaladvisor.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Thu, 19 Sep 2019 08:23:51 GMT
last-modified
Mon, 29 Apr 2019 21:54:35 GMT
server
ESF
age
60353
status
200
x-frame-options
SAMEORIGIN
content-type
font/woff2
access-control-allow-origin
*
cache-control
private, max-age=86400
content-disposition
attachment; filename="font.woff2"; filename*=UTF-8''font.woff2
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
12125
x-xss-protection
0
expires
Thu, 19 Sep 2019 08:23:51 GMT
ads
securepubads.g.doubleclick.net/gampad/
8 KB
4 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=737522423887320&correlator=1787422106114685&output=ldjh&callback=googletag.impl.pubads.callbackProxy1&impl=fif&adsid=NT&eid=21062833%2C21063636&vrg=2019091201&guci=1.2.0.0.2.2.0.0&plat=1%3A32776%2C2%3A16809992%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20190920&iu=%2F5745%2Fca_us%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2FOOP_prestitial&sz=1x1&ists=1&scp=pos%3DOOP_prestitial&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DHaymarket%2520Media%26postID%3D94006%26env%3Dlive%26sid%3DAllergy_and_Immunology_Information_Center%252CNews%26styleid%3D%26cat%3DAllergy_%2526amp%253B_Immunology%26atype%3DHealthday%26block%3DCA_Abilify_Maintena_2019%252CCA_Symtuza_2019%252CHMN_Rexulti_2019%252CMPR_JanssenDermatology_2019%252CTest%26isnht%3Dfalse%26browser%3DChrome%252074%26amid%3D6b84c5dc012a68d3e1bb886bfca683bfa0a3abec27a316170eac1e947c5c7fac%26spr%3D448%26ssp%3D%26cpn%3Dobgyn_md%252Celagolix_august2018%252Cobgyn_all%252Charvonitbg%252Cverzenio122018%252Cxxxx%252CPVC2019127035%252Csaxendaunbranded_feb2019%252Cintrarosa_feb2019%26subid%3D0%26usrc%3Dhaymarket%26eid%3D57cba5946efbce1c33a53f2b26ef549736a7058933221787043724da633564e9%26LyticsSegments%3Dga_med_nomycme%252Cga_med_nht_false%252Cmycme_rheum_survey_audience%252C3_day_visitors_neuro_ca_empr%252Cblackfriday_notunknown%252Cactivity_5126_audience%252Cmycme_endofyearsale_noanonymous_nosdc%252Caudience_for_mlk_sale%252Cnot_unknown_5770%252Cmycme_activity_5762%252Cactivity_5772_mycme_no_unknown_no_pulm%252Cddw_opened_to_all%252Call%252Csmt_new%252Cly_reporting_from_email%252Cly_reporting_has_visited_web%252Cly_reporting_multi_session_visitor%252Cly_reporting_last_visit_within_day%252Cly_reporting_last_visit_within_week%252Cly_reporting_last_visit_within_month%252Cly_reporting_last_visit_within_3_months%252Cly_known_email%252Cly_repeat_visitor%252Cly_international_visitor%252Cly_uses_desktop%252Cly_from_email%252Cknown%252Csite_known_ca%252Cce_salary_survey_promo_on_ca%252Call_time_visitors%252Cmycme_allergy_all_except_4797_completes%252Cmycme_hiv_all_except_4670_completes%252Cmycme_internal_med_all_except_4670_completes%252Cmycme_allergy_all_except_4744_completes%252Cmycme_psychiatry_all_except_4812_completes%252Cmycme_cardiology_all_except_cardiology_pas%252Cmycme_dermatology_all_except_4831_completes%252Cmycme_pediatrics_all_except_4354_completes%252Cmycme_acc_next_activity_promo_no_4523%252Cmycme_acc_next_activity_promo_no_4524%252Cmycme_acc_next_activity_promo_no_4525%252Cmycme_acc_next_activity_promo_no_4526%252Cmycme_acc_next_activity_promo_no_4593%252Cmycme_acc_next_activity_promo_no_4595%252Cmycme_acc_next_activity_promo_no_4710%252Cmycme_acc_next_activity_promo_no_4804%252Cmycme_acc_next_activity_promo_no_4834%252Cmycme_acc_next_activity_promo_no_4800%252Cmycme_acc_next_activity_promo_no_4792%252Cmycme_acc_next_activity_promo_no_4511%252Cmycme_acc_next_activity_promo_no_4529%252Cmycme_acc_next_activity_promo_no_4558%252Cmycme_acc_next_activity_promo_no_4634%252Cmycme_impact_next_activity_promo_no_4740%252Cmycme_impact_next_activity_promo_no_4757%252Cmycme_impact_next_activity_promo_no_4842%252Cmycme_impact_next_activity_promo_no_4816%252Cmycme_impact_next_activity_promo_no_4897%252Cmycme_impact_next_activity_promo_no_4727%252Cmycme_impact_next_activity_promo_no_4755%252Cmycme_impact_next_activity_promo_no_4791%252Cmycme_impact_next_activity_promo_no_47911%252Cmycme_impact_next_activity_promo_no_4826%252Cmycme_impact_next_activity_promo_no_4815%252Cce_excluding_mpr_print_subscribers%252Cce_excluding_ca_print_subscribers%252Cga_med_known%252Cmycme_homepage_ibs_town_wall_%252Cmycme_ddw_nash%252Cemailops060619%252Cmycme_activity_5841_2%252Cmycme_pediatrics_activity_5591&cookie_enabled=1&bc=31&abxe=1&lmt=1568941784&dt=1568941784391&dlt=1568941782685&idt=647&frm=20&biw=1585&bih=1200&oid=3&adx=0&ady=2693&adk=1807965959&uci=1&ifi=1&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&dssz=82&icsg=152282377224192&mso=67108864&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=1585x2694&msz=1585x1&ga_vid=719138576.1568941783&ga_sid=1568941784&ga_hid=1445100269&fws=4&ohw=1585
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019091201.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.206.2 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s20-in-f2.1e100.net
Software
cafe /
Resource Hash
f2dbe9c92c7dd4152bcf60f2b11bca884d26f4afe87bdade8619225904de2d97
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:44 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
3161
x-xss-protection
0
google-lineitem-id
132785185
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138274707450
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.clinicaladvisor.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
pubads_impl_rendering_2019091201.js
securepubads.g.doubleclick.net/gpt/
62 KB
24 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091201.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019091201.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.206.2 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s20-in-f2.1e100.net
Software
sffe /
Resource Hash
7c92ffc225aed56f82019862b155c8d84902352620250d029bbf653a3d7eab61
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:44 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Thu, 12 Sep 2019 13:06:13 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
24116
x-xss-protection
0
expires
Fri, 20 Sep 2019 01:09:44 GMT
container.html
tpc.googlesyndication.com/safeframe/1-0-35/html/
0
0
Other
General
Full URL
https://tpc.googlesyndication.com/safeframe/1-0-35/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019091201.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:814::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Clinician-Infant-Pediatrics_G_603707029-1024x683.jpg
www.clinicaladvisor.com/wp-content/uploads/sites/11/2019/04/
80 KB
81 KB
Image
General
Full URL
https://www.clinicaladvisor.com/wp-content/uploads/sites/11/2019/04/Clinician-Infant-Pediatrics_G_603707029-1024x683.jpg
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
cdfd1fc9d918ad07c64d83083e4955c3651c7e218faf2272f5e08bfed87bbdaa
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 20 Sep 2019 01:09:44 GMT
last-modified
Mon, 22 Apr 2019 07:11:21 GMT
server
nginx
etag
"823b2c8eaa7e70167b79290385adb10c"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
82270
expires
Sun, 20 Oct 2019 01:09:44 GMT
sepsisssss21258002_1449816.jpg
www.clinicaladvisor.com/wp-content/uploads/sites/11/2019/02/
1 MB
1 MB
Image
General
Full URL
https://www.clinicaladvisor.com/wp-content/uploads/sites/11/2019/02/sepsisssss21258002_1449816.jpg
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
0aeca196415cd9393b64c79d2276e2d60e2d31c9242c6a9dba0fc94e433ceeb4
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 20 Sep 2019 01:09:44 GMT
last-modified
Fri, 22 Mar 2019 08:17:43 GMT
server
nginx
etag
"eebfd925fcc4256f27612ba250f9f794"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
1544952
expires
Sun, 20 Oct 2019 01:09:44 GMT
rheulogo_887494.png
media.rheumatologyadvisor.com/images/2015/12/18/
5 KB
5 KB
Image
General
Full URL
https://media.rheumatologyadvisor.com/images/2015/12/18/rheulogo_887494.png
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.214.25 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-214-25.fra53.r.cloudfront.net
Software
Microsoft-IIS/8.5 /
Resource Hash
ac4b41978c5ad32097bbd2e698ae565d1f6dd331f65213f17b70e2611efc4c8c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sun, 19 May 2019 17:57:14 GMT
Via
1.1 8b5bc0831e6dab612582614c3009efa7.cloudfront.net (CloudFront)
Age
10653058
X-Cache
Hit from cloudfront
Connection
keep-alive
Content-Length
4853
Last-Modified
Mon, 18 Jan 2016 18:41:08 GMT
Server
Microsoft-IIS/8.5
ETag
"03a60cb1f52d11:0"
Content-Type
image/png
Access-Control-Allow-Origin
*
Cache-Control
max-age=31536000
ImageFrom
New-Image
X-Amz-Cf-Pop
FRA53-C1
Accept-Ranges
bytes
X-Amz-Cf-Id
5o_3NQ0PPIS3oyRq0Jojx6bXjIhE1odzNlkhMzVI9mgcisjMZw4buQ==
cervicalcancer-article_454628.jpg
www.clinicaladvisor.com/wp-content/uploads/sites/11/2019/02/
158 KB
159 KB
Image
General
Full URL
https://www.clinicaladvisor.com/wp-content/uploads/sites/11/2019/02/cervicalcancer-article_454628.jpg
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
1f89b1864caf3f011414af33d5264920416276b828f36d53d777bff204cf1b74
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 20 Sep 2019 01:09:44 GMT
last-modified
Fri, 22 Mar 2019 08:14:26 GMT
server
nginx
etag
"2fccc80a7b9652bd1a1777695ea58666"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
162284
expires
Sun, 20 Oct 2019 01:09:44 GMT
ca1112celiac_abpain_316827.jpg
www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2019/06/
55 KB
55 KB
Image
General
Full URL
https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2019/06/ca1112celiac_abpain_316827.jpg
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.94.35.144 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-94-35-144.compute-1.amazonaws.com
Software
nginx /
Resource Hash
c7007fd5ef81d132c34017c326d661fea28c536df21cd6c4e723f9f316a2d0f6
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 20 Sep 2019 01:09:44 GMT
last-modified
Wed, 03 Jul 2019 07:25:45 GMT
server
nginx
etag
"ec274c90ca7d8e7e9a495f5aec9cef75"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
56397
expires
Sun, 20 Oct 2019 01:09:44 GMT
warfaring637701730_1372442.jpg
www.clinicaladvisor.com/wp-content/uploads/sites/11/2019/02/
145 KB
145 KB
Image
General
Full URL
https://www.clinicaladvisor.com/wp-content/uploads/sites/11/2019/02/warfaring637701730_1372442.jpg
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
b87381f6e946a389f02896319a32cb6d243ed48fc69783707ca1e059baf6a2a8
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 20 Sep 2019 01:09:44 GMT
last-modified
Thu, 21 Mar 2019 15:59:23 GMT
server
nginx
etag
"a19206d2658c487019f6ff69102fcbb5"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
148127
expires
Sun, 20 Oct 2019 01:09:44 GMT
olderwomanmenopausetreatmen_1342515.jpg
www.clinicaladvisor.com/wp-content/uploads/sites/11/2018/12/
184 KB
184 KB
Image
General
Full URL
https://www.clinicaladvisor.com/wp-content/uploads/sites/11/2018/12/olderwomanmenopausetreatmen_1342515.jpg
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
b2995762322862408db81a0ede3a3d674996cbf26f6812d926ca4f38f4aaa693
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 20 Sep 2019 01:09:44 GMT
last-modified
Fri, 22 Mar 2019 10:33:44 GMT
server
nginx
etag
"e09812a229db96fa35eb8fa0ee9483be"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
188133
expires
Sun, 20 Oct 2019 01:09:44 GMT
endologobiew_784698.png
media.endocrinologyadvisor.com/images/2015/06/11/
6 KB
6 KB
Image
General
Full URL
https://media.endocrinologyadvisor.com/images/2015/06/11/endologobiew_784698.png
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.35.253.32 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-35-253-32.fra6.r.cloudfront.net
Software
Microsoft-IIS/8.5 /
Resource Hash
c7d7a36417ff60b8e7e9ad1d4371f1f16c993ed6e5ce8033ea145fc4b8422150

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sat, 01 Jun 2019 21:44:53 GMT
Via
1.1 2ef0748a2a8fca13fd6065b6b046c33c.cloudfront.net (CloudFront)
Age
9516183
X-Cache
Hit from cloudfront
Connection
keep-alive
Content-Length
5949
Last-Modified
Fri, 11 Dec 2015 16:34:39 GMT
Server
Microsoft-IIS/8.5
ETag
"803948d43134d11:0"
Content-Type
image/png
Access-Control-Allow-Origin
*
Cache-Control
max-age=31536000
ImageFrom
New-Image
X-Amz-Cf-Pop
FRA6-C1
Accept-Ranges
bytes
X-Amz-Cf-Id
BeznQGhPzfn87Rvu4NmExTTO-TCAot-ieE7mDqKFTTScJdGOS1CCkA==
ch857.fig1_.jpg
www.clinicaladvisor.com/wp-content/uploads/sites/11/2019/02/
190 KB
190 KB
Image
General
Full URL
https://www.clinicaladvisor.com/wp-content/uploads/sites/11/2019/02/ch857.fig1_.jpg
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
45a0f15522ac22c19340e5f292169659c2852446e4c4b1afacd331110f07c577
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 20 Sep 2019 01:09:44 GMT
last-modified
Thu, 21 Mar 2019 16:01:44 GMT
server
nginx
etag
"f76c23c395e4269e1c21c7b1ac87155b"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
194323
expires
Sun, 20 Oct 2019 01:09:44 GMT
pulmonaryembolismg605383449_1423763.jpg
www.clinicaladvisor.com/wp-content/uploads/sites/11/2019/02/
240 KB
241 KB
Image
General
Full URL
https://www.clinicaladvisor.com/wp-content/uploads/sites/11/2019/02/pulmonaryembolismg605383449_1423763.jpg
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
d10af34a9c36e884cda714c084d1be3bf11d257360a815ba74bd44de76127307
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 20 Sep 2019 01:09:44 GMT
last-modified
Fri, 22 Mar 2019 08:41:11 GMT
server
nginx
etag
"d465fcfe44522e103b6b5abea160b012"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
245748
expires
Sun, 20 Oct 2019 01:09:44 GMT
logo684531_784586.png
media.clinicaladvisor.com/images/2015/06/11/
3 KB
3 KB
Image
General
Full URL
http://media.clinicaladvisor.com/images/2015/06/11/logo684531_784586.png
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
HTTP/1.1
Server
143.204.214.39 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-214-39.fra53.r.cloudfront.net
Software
Microsoft-IIS/8.5 /
Resource Hash
8b4369153780828bff5de99459130adede56d907d9ac3a2275a22ac249d9fe4e

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sun, 05 May 2019 07:47:27 GMT
Via
1.1 16dc09493f48bbc1fd2cdd6e175a94f7.cloudfront.net (CloudFront)
Age
11899262
X-Cache
Hit from cloudfront
Connection
keep-alive
Content-Length
2946
Last-Modified
Sat, 05 Dec 2015 16:21:21 GMT
Server
Microsoft-IIS/8.5
ETag
"809628fa782fd11:0"
Content-Type
image/png
Access-Control-Allow-Origin
*
Cache-Control
max-age=31536000
ImageFrom
New-Image
X-Amz-Cf-Pop
FRA53-C1
Accept-Ranges
bytes
X-Amz-Cf-Id
YpgzGV1jP4s_LXKXNnCvgOwg1J_BFgxZ7rULk2hi5HL6RYqJ9pk18w==
cta061115_784552.png
media.chemotherapyadvisor.com/images/2015/06/11/
7 KB
7 KB
Image
General
Full URL
https://media.chemotherapyadvisor.com/images/2015/06/11/cta061115_784552.png
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.35.253.49 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-35-253-49.fra6.r.cloudfront.net
Software
Microsoft-IIS/8.5 /
Resource Hash
701254daa9cfe1258e9073c729c08c61b9552ce69cff28620c5f8052b10e600f

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Thu, 30 May 2019 09:31:29 GMT
Via
1.1 25c6baf0a31a5ef699c1e219b25ce7b9.cloudfront.net (CloudFront)
Age
9732991
X-Cache
Hit from cloudfront
Connection
keep-alive
Content-Length
6999
Last-Modified
Sat, 05 Dec 2015 16:28:50 GMT
Server
Microsoft-IIS/8.5
ETag
"08dc857a2fd11:0"
Content-Type
image/png
Access-Control-Allow-Origin
*
Cache-Control
max-age=31536000
ImageFrom
New-Image
X-Amz-Cf-Pop
FRA6-C1
Accept-Ranges
bytes
X-Amz-Cf-Id
rU4vYFlCVU_eTPX-RApRS5u_QiADz7XfssUJxN7CTh5TRgWybpyYUA==
headacheg503847947_1493406.jpg
www.clinicaladvisor.com/wp-content/uploads/sites/11/2019/05/
582 KB
583 KB
Image
General
Full URL
https://www.clinicaladvisor.com/wp-content/uploads/sites/11/2019/05/headacheg503847947_1493406.jpg
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
8fa10b36a7cfc0340eda914b598537b74ddb833ece97478e1387899ccbd14d3b
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 20 Sep 2019 01:09:44 GMT
last-modified
Tue, 11 Jun 2019 07:11:27 GMT
server
nginx
etag
"e551ee1ae8737d7f5ea61d54f93303ab"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
596431
expires
Sun, 20 Oct 2019 01:09:44 GMT
logo684531_784586.png
media.clinicaladvisor.com/images/2015/06/11/
3 KB
3 KB
Image
General
Full URL
https://media.clinicaladvisor.com/images/2015/06/11/logo684531_784586.png
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.214.39 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-214-39.fra53.r.cloudfront.net
Software
Microsoft-IIS/8.5 /
Resource Hash
8b4369153780828bff5de99459130adede56d907d9ac3a2275a22ac249d9fe4e

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sun, 05 May 2019 07:47:27 GMT
Via
1.1 85dc19f43b2a0bd8840fdf8baf07d762.cloudfront.net (CloudFront)
Age
11899262
X-Cache
Hit from cloudfront
Connection
keep-alive
Content-Length
2946
Last-Modified
Sat, 05 Dec 2015 16:21:21 GMT
Server
Microsoft-IIS/8.5
ETag
"809628fa782fd11:0"
Content-Type
image/png
Access-Control-Allow-Origin
*
Cache-Control
max-age=31536000
ImageFrom
New-Image
X-Amz-Cf-Pop
FRA53-C1
Accept-Ranges
bytes
X-Amz-Cf-Id
wbnfOeFxmH3n_CJCpE504IEMP99JrUUEgniTiA3zzr3Catu3ZXjO3Q==
stressedblackfemaleclinicia_1491474.jpg
www.clinicaladvisor.com/wp-content/uploads/sites/11/2018/12/
525 KB
525 KB
Image
General
Full URL
https://www.clinicaladvisor.com/wp-content/uploads/sites/11/2018/12/stressedblackfemaleclinicia_1491474.jpg
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
7b56b8f09dd464125e18ea19d4446f4e8149e44f70cf46af6bdbff7e1307879a
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 20 Sep 2019 01:09:44 GMT
last-modified
Fri, 22 Mar 2019 08:50:19 GMT
server
nginx
etag
"636c2303a8fd0977ed2b382d18988355"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
537263
expires
Sun, 20 Oct 2019 01:09:44 GMT
black.woman_.hospital_G_123317880.jpg
www.clinicaladvisor.com/wp-content/uploads/sites/11/2019/07/
100 KB
101 KB
Image
General
Full URL
https://www.clinicaladvisor.com/wp-content/uploads/sites/11/2019/07/black.woman_.hospital_G_123317880.jpg
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
330a5ecbee96dc12c42d8c5072b09406231e16a114cfffab03a3f6c8a445562f
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 20 Sep 2019 01:09:44 GMT
last-modified
Mon, 22 Jul 2019 07:11:02 GMT
server
nginx
etag
"a9394f482d02bb732baa1845f1b91f29"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
102626
expires
Sun, 20 Oct 2019 01:09:44 GMT
vtearteryg724234021_1456804.jpg
www.clinicaladvisor.com/wp-content/uploads/sites/11/2019/02/
922 KB
923 KB
Image
General
Full URL
https://www.clinicaladvisor.com/wp-content/uploads/sites/11/2019/02/vtearteryg724234021_1456804.jpg
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
a6ed14c9ce70e35e652e832c23a9acb7ff43ede312e0596fe74ab7a7cb369b04
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 20 Sep 2019 01:09:44 GMT
last-modified
Thu, 21 Mar 2019 16:09:00 GMT
server
nginx
etag
"b370fdd9ad671cf25d566e8ee2bc6c36"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
944079
expires
Sun, 20 Oct 2019 01:09:44 GMT
womanstomachpainpillsresiz_1396827.jpg
www.clinicaladvisor.com/wp-content/uploads/sites/11/2018/12/
134 KB
134 KB
Image
General
Full URL
https://www.clinicaladvisor.com/wp-content/uploads/sites/11/2018/12/womanstomachpainpillsresiz_1396827.jpg
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
54de755d1f2a4f40363964d7ed08b4166c2a42bd7e3f17b695773e253369aec9
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 20 Sep 2019 01:09:44 GMT
last-modified
Fri, 22 Mar 2019 10:43:36 GMT
server
nginx
etag
"d1ee5bbb31bf115399ccbac2f1b977f8"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
137172
expires
Sun, 20 Oct 2019 01:09:44 GMT
softdrinksodag533575209_1271970.jpg
www.clinicaladvisor.com/wp-content/uploads/sites/11/2018/12/
174 KB
174 KB
Image
General
Full URL
https://www.clinicaladvisor.com/wp-content/uploads/sites/11/2018/12/softdrinksodag533575209_1271970.jpg
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
c38021b389af2ab39af2a180a2d21660de211930cbd5fd77130f4df7c2dbd363
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 20 Sep 2019 01:09:44 GMT
last-modified
Fri, 22 Mar 2019 15:41:34 GMT
server
nginx
etag
"a36784266604002098c53126283d4c4e"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
178074
expires
Sun, 20 Oct 2019 01:09:44 GMT
atopicdermatitisg165665917_1503756.jpg
www.clinicaladvisor.com/wp-content/uploads/sites/11/2019/02/
536 KB
536 KB
Image
General
Full URL
https://www.clinicaladvisor.com/wp-content/uploads/sites/11/2019/02/atopicdermatitisg165665917_1503756.jpg
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
9a55553f260890488c1f138a073c9d77fd738cb50b051932a0ad32acb87ab2c1
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 20 Sep 2019 01:09:44 GMT
last-modified
Thu, 21 Mar 2019 16:01:13 GMT
server
nginx
etag
"9405ee98c52506e774e9688dd17991fa"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
548435
expires
Sun, 20 Oct 2019 01:09:44 GMT
ketogenicdietg868355756_1337477.jpg
www.clinicaladvisor.com/wp-content/uploads/sites/11/2018/12/
198 KB
199 KB
Image
General
Full URL
https://www.clinicaladvisor.com/wp-content/uploads/sites/11/2018/12/ketogenicdietg868355756_1337477.jpg
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
cb8dcdf68d92f78695c69b7cd7e8bfbb083fe214193ef6a4dfd55d1e0e26c841
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 20 Sep 2019 01:09:44 GMT
last-modified
Fri, 22 Mar 2019 08:42:57 GMT
server
nginx
etag
"eaacaacb9d5dbb098e502e27db87c8d9"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
203024
expires
Sun, 20 Oct 2019 01:09:44 GMT
hospitalg114857407_1453911.jpg
www.clinicaladvisor.com/wp-content/uploads/sites/11/2019/02/
2 MB
2 MB
Image
General
Full URL
https://www.clinicaladvisor.com/wp-content/uploads/sites/11/2019/02/hospitalg114857407_1453911.jpg
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
ff429964a3e2da17b23894a5442628a0862df51f1ac248f09563f3fabc834cc1
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 20 Sep 2019 01:09:44 GMT
last-modified
Thu, 21 Mar 2019 16:10:47 GMT
server
nginx
etag
"4e9c647437f2e159baacb9e98c5af0d7"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
1729394
expires
Sun, 20 Oct 2019 01:09:44 GMT
ch1240.fig1_.jpg
www.clinicaladvisor.com/wp-content/uploads/sites/11/2019/02/
45 KB
45 KB
Image
General
Full URL
https://www.clinicaladvisor.com/wp-content/uploads/sites/11/2019/02/ch1240.fig1_.jpg
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
85a36c50c8c94bcf0da8793c47730dab4cbde54b86f849751721f9e9daf2206c
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 20 Sep 2019 01:09:44 GMT
last-modified
Thu, 21 Mar 2019 16:07:34 GMT
server
nginx
etag
"65c76aa3d5c6696b18abcc7c25f23bbe"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
45847
expires
Sun, 20 Oct 2019 01:09:44 GMT
homelessmang701068912_1496816.jpg
www.clinicaladvisor.com/wp-content/uploads/sites/11/2019/02/
938 KB
939 KB
Image
General
Full URL
https://www.clinicaladvisor.com/wp-content/uploads/sites/11/2019/02/homelessmang701068912_1496816.jpg
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
7ce0821c61d72949dac241e8da27566f1f6a94e22da3e3811fa27ae4116c7bc3
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 20 Sep 2019 01:09:44 GMT
last-modified
Fri, 22 Mar 2019 08:19:16 GMT
server
nginx
etag
"1191ef8dec1192ca9c9645e194e88e56"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
960466
expires
Sun, 20 Oct 2019 01:09:44 GMT
truncated
/ Frame 08C8
215 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
bc9dc76286eb922000fe776556067a9373dc8ae44b20d3a146112783a57d3913

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
osd.js
www.googletagservices.com/activeview/js/current/
77 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd.js?cb=%2Fr20100101
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019091201.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:818::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
41ad8ff7e5205f7360535566ad386abb370abb9b92af19005a7ded4a803faf28
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:44 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1568805556061895"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
29138
x-xss-protection
0
expires
Fri, 20 Sep 2019 01:09:44 GMT
imgad
tpc.googlesyndication.com/pagead/
Redirect Chain
  • https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsud5pqNuFOUtH8ZgaMd9-0-qtlAZuDhS98uxD5zBGrWPgX8TcH1ntXmENh-dBQjDU4qQeCJ2Ph4IO6v_q8APmsyEt4h3v25lkgkd8a3-QlW8kbPz2B0ipe3BAkJoPT6J4Fmmw7pvEfdE...
  • https://tpc.googlesyndication.com/pagead/imgad?id=CICAgKDHyqHSjgEQARgBMghpUBQmFaL9aw
151 KB
152 KB
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/imgad?id=CICAgKDHyqHSjgEQARgBMghpUBQmFaL9aw
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:814::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
df42aa09be86879bfd4e405fa50b9c58b54c103c76341e2f23e462041ca34b04
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 15 Sep 2019 12:01:22 GMT
x-content-type-options
nosniff
server
cafe
age
392902
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
content-type
image/gif
status
200
cache-control
public, max-age=604800
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
155024
x-xss-protection
0
expires
Sun, 22 Sep 2019 12:01:22 GMT

Redirect headers

timing-allow-origin
*
date
Fri, 20 Sep 2019 01:09:44 GMT
x-content-type-options
nosniff
server
cafe
status
302
location
https://tpc.googlesyndication.com/pagead/imgad?id=CICAgKDHyqHSjgEQARgBMghpUBQmFaL9aw
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
text/html; charset=UTF-8
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
0
x-xss-protection
0
registration-profession
subapi.haymarketmedia.com/
589 B
876 B
XHR
General
Full URL
https://subapi.haymarketmedia.com/registration-profession?countryCode=US
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?ver=0.1.1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.172.78.117 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-35-172-78-117.compute-1.amazonaws.com
Software
/ Express
Resource Hash
808e5dda9ebf9cae0ae42a7f53c8c335e6f2951724c8a58c15658d0fdd49b61f

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

date
Fri, 20 Sep 2019 01:09:44 GMT
x-powered-by
Express
etag
W/"24d-pNT5lZLPsLHhX4AYX72K6qXLTk4"
status
200
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/json; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
589
registration-specialty
subapi.haymarketmedia.com/
2 KB
2 KB
XHR
General
Full URL
https://subapi.haymarketmedia.com/registration-specialty?countryCode=US
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?ver=0.1.1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.172.78.117 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-35-172-78-117.compute-1.amazonaws.com
Software
/ Express
Resource Hash
2ccc2d6a6ce64b8e30228624183547c2456f8d9597ca456d147f47e95f4fe443

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

date
Fri, 20 Sep 2019 01:09:44 GMT
x-powered-by
Express
etag
W/"686-ZUbw46JA9hG3Fv9uXg61Vkj0+q0"
status
200
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/json; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
1670
truncated
/
88 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
65af014c9562d3ef38dbb4638bef464aa19d2c5899e1872b6ec96da9046168e5

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/svg+xml;charset=utf-8
/
adtrackapi.haymarketmedia.com/adverttracking/
2 B
367 B
XHR
General
Full URL
https://adtrackapi.haymarketmedia.com/adverttracking/
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2057:600:16:bc48:4dc0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-type
application/json

Response headers

date
Fri, 20 Sep 2019 01:09:45 GMT
via
1.1 d5fb859c39a16d7f218b4c7fb1528ad6.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA6-C1
x-amzn-requestid
eb198b78-cc49-44d8-8224-4e3706bc6a91
status
200
x-cache
Miss from cloudfront
content-type
application/json
access-control-allow-origin
*
x-amzn-trace-id
Root=1-5d8426d9-6d8881cdd53a5cbd36175170;Sampled=0
x-amz-apigw-id
ASsB9H87IAMFnLw=
content-length
2
x-amz-cf-id
-P7WXYvCaU2aV3se9Q55bUc4ho4p7YkWNFFkEaB4S-zEcMfZGV2RRg==
ads
securepubads.g.doubleclick.net/gampad/
20 KB
6 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=737522423887320&correlator=1787422106114685&output=ldjh&callback=googletag.impl.pubads.callbackProxy2&impl=fif&adsid=NT&eid=21062833%2C21063636&vrg=2019091201&guci=1.2.0.0.2.2.0.0&plat=1%3A32776%2C2%3A16809992%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20190920&iu=%2F5745%2Fca_us%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Fleaderboard_top&sz=728x90&scp=pos%3Dleaderboard_top&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DHaymarket%2520Media%26postID%3D94006%26env%3Dlive%26sid%3DAllergy_and_Immunology_Information_Center%252CNews%26styleid%3D%26cat%3DAllergy_%2526amp%253B_Immunology%26atype%3DHealthday%26block%3DCA_Abilify_Maintena_2019%252CCA_Symtuza_2019%252CHMN_Rexulti_2019%252CMPR_JanssenDermatology_2019%252CTest%26isnht%3Dfalse%26browser%3DChrome%252074%26amid%3D6b84c5dc012a68d3e1bb886bfca683bfa0a3abec27a316170eac1e947c5c7fac%26spr%3D448%26ssp%3D%26cpn%3Dobgyn_md%252Celagolix_august2018%252Cobgyn_all%252Charvonitbg%252Cverzenio122018%252Cxxxx%252CPVC2019127035%252Csaxendaunbranded_feb2019%252Cintrarosa_feb2019%26subid%3D0%26usrc%3Dhaymarket%26eid%3D57cba5946efbce1c33a53f2b26ef549736a7058933221787043724da633564e9%26LyticsSegments%3Dga_med_nomycme%252Cga_med_nht_false%252Cmycme_rheum_survey_audience%252C3_day_visitors_neuro_ca_empr%252Cblackfriday_notunknown%252Cactivity_5126_audience%252Cmycme_endofyearsale_noanonymous_nosdc%252Caudience_for_mlk_sale%252Cnot_unknown_5770%252Cmycme_activity_5762%252Cactivity_5772_mycme_no_unknown_no_pulm%252Cddw_opened_to_all%252Call%252Csmt_new%252Cly_reporting_from_email%252Cly_reporting_has_visited_web%252Cly_reporting_multi_session_visitor%252Cly_reporting_last_visit_within_day%252Cly_reporting_last_visit_within_week%252Cly_reporting_last_visit_within_month%252Cly_reporting_last_visit_within_3_months%252Cly_known_email%252Cly_repeat_visitor%252Cly_international_visitor%252Cly_uses_desktop%252Cly_from_email%252Cknown%252Csite_known_ca%252Cce_salary_survey_promo_on_ca%252Call_time_visitors%252Cmycme_allergy_all_except_4797_completes%252Cmycme_hiv_all_except_4670_completes%252Cmycme_internal_med_all_except_4670_completes%252Cmycme_allergy_all_except_4744_completes%252Cmycme_psychiatry_all_except_4812_completes%252Cmycme_cardiology_all_except_cardiology_pas%252Cmycme_dermatology_all_except_4831_completes%252Cmycme_pediatrics_all_except_4354_completes%252Cmycme_acc_next_activity_promo_no_4523%252Cmycme_acc_next_activity_promo_no_4524%252Cmycme_acc_next_activity_promo_no_4525%252Cmycme_acc_next_activity_promo_no_4526%252Cmycme_acc_next_activity_promo_no_4593%252Cmycme_acc_next_activity_promo_no_4595%252Cmycme_acc_next_activity_promo_no_4710%252Cmycme_acc_next_activity_promo_no_4804%252Cmycme_acc_next_activity_promo_no_4834%252Cmycme_acc_next_activity_promo_no_4800%252Cmycme_acc_next_activity_promo_no_4792%252Cmycme_acc_next_activity_promo_no_4511%252Cmycme_acc_next_activity_promo_no_4529%252Cmycme_acc_next_activity_promo_no_4558%252Cmycme_acc_next_activity_promo_no_4634%252Cmycme_impact_next_activity_promo_no_4740%252Cmycme_impact_next_activity_promo_no_4757%252Cmycme_impact_next_activity_promo_no_4842%252Cmycme_impact_next_activity_promo_no_4816%252Cmycme_impact_next_activity_promo_no_4897%252Cmycme_impact_next_activity_promo_no_4727%252Cmycme_impact_next_activity_promo_no_4755%252Cmycme_impact_next_activity_promo_no_4791%252Cmycme_impact_next_activity_promo_no_47911%252Cmycme_impact_next_activity_promo_no_4826%252Cmycme_impact_next_activity_promo_no_4815%252Cce_excluding_mpr_print_subscribers%252Cce_excluding_ca_print_subscribers%252Cga_med_known%252Cmycme_homepage_ibs_town_wall_%252Cmycme_ddw_nash%252Cemailops060619%252Cmycme_activity_5841_2%252Cmycme_pediatrics_activity_5591&cookie=ID%3D614ed1437d8147f5%3AT%3D1568941784%3AS%3DALNI_MYPGKvGCVYQXF5NJ7iDQhpczIcS6A&cookie_enabled=1&bc=31&abxe=1&lmt=1568941785&dt=1568941785283&dlt=1568941782685&idt=647&frm=20&biw=1585&bih=1200&oid=3&adx=212&ady=102&adk=3943181460&uci=2&ifi=2&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&dssz=83&icsg=152282377224192&mso=67108864&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=942x-1&msz=942x-1&psts=CioIocioP-gB-q_CjoMEggIQsbmAD4GY8iH5mPIh0dPPNNECBvd4dQ-tf8s&ga_vid=719138576.1568941783&ga_sid=1568941784&ga_hid=1445100269&fws=516&ohw=1585
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019091201.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.206.2 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s20-in-f2.1e100.net
Software
cafe /
Resource Hash
d4ab90a22f17b3d865d1c31c9f750eb2bf6b6aa7287b2042e3b525df8a865b08
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:45 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
5776
x-xss-protection
0
google-lineitem-id
4372559252
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138207221056
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.clinicaladvisor.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame DD1D
0
56 B
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstAz0sukIGNOQdZpUQco2UEYuVC_hi1zxWMRcSWs6meS6zGrTTM9utphmVl6cdXL8H7AaPTTn01vaKZiLu8kTPYrCfnwgGYaOqJF9wil4b8lgi4rqKt03XrUjLbAT6Sm3RTWiDDhXj0hLySLWTQ1M7OYmH4LYi5xYOws3bPHBaDcJ4H-LMDxgMnS5HRHKbCfUo6Ns1GRsvRorgTM6QoAdUvZcB5BBBOmDvhDkJVBbALw-HoMtmLx8MqpLS26lDqC0Nxq6DV6ik42nlSMfse47Q7vR3EvZIgeLn2YO8kdVW4xpp8A5UYICX1C0WjBFdeJZBXz5-48PevezuoP_L2DZN73Xi6qvevIjI&sig=Cg0ArKJSzMc28QOZ6NbfEAE&adurl=
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.206.2 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s20-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 20 Sep 2019 01:09:45 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
0
x-xss-protection
0
window_focus.js
tpc.googlesyndication.com/pagead/js/r20190918/r20110914/client/ Frame DD1D
2 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20190918/r20110914/client/window_focus.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091201.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:814::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
d31b12baad65082a7d404da9971cc9fed871e35f29a5893f815f468f1050491f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Wed, 18 Sep 2019 14:11:02 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
125923
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
1044
x-xss-protection
0
server
cafe
etag
16885093947315342629
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Wed, 02 Oct 2019 14:11:02 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame DD1D
78 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091201.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:818::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
96d487a0c7dd457eb22a400e8861a2edc90596164a67684fbe4715713e9fad7d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:45 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1568805556061895"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
29649
x-xss-protection
0
expires
Fri, 20 Sep 2019 01:09:45 GMT
init-132dn9au2z77uqg0m5w.js
api.b2c.com/api/ Frame DD1D
13 KB
5 KB
Script
General
Full URL
https://api.b2c.com/api/init-132dn9au2z77uqg0m5w.js?AdUnitID_TopLevel=71076865&AdUnitID=110356945&AdvertiserID=21701905&OrderID=325626025&LineItemID=4372559252&CreativeID=138207221056&CPN=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&sid=Allergy_and_Immunology_Information_Center,News
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091201.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5802:b76e:7a35:805d:7afc Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
980f556e15e5df383c4ce300e013fd67bff2739da34b8eb96954bc4d8d1cb920

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:45 GMT
content-encoding
gzip
server
openresty
content-type
text/javascript
status
200
cache-control
no-cache, no-store, must-revalidate
expires
-1
1749941608810051252
tpc.googlesyndication.com/simgad/ Frame DD1D
71 KB
71 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/1749941608810051252
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091201.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:814::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
da2dde0a707f9c7124e1fce92f5328561ac851816fcc8a1c11065afbeed4d031
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 15 Sep 2019 00:21:56 GMT
x-content-type-options
nosniff
age
434869
x-dns-prefetch-control
off
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
72425
x-xss-protection
0
last-modified
Thu, 27 Jul 2017 15:12:26 GMT
server
sffe
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Mon, 14 Sep 2020 00:21:56 GMT
ads
securepubads.g.doubleclick.net/gampad/
20 KB
6 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=737522423887320&correlator=1787422106114685&output=ldjh&callback=googletag.impl.pubads.callbackProxy3&impl=fif&adsid=NT&eid=21062833%2C21063636&vrg=2019091201&guci=1.2.0.0.2.2.0.0&plat=1%3A32776%2C2%3A16809992%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20190920&iu=%2F5745%2Fca_us%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Fbox_1&sz=300x250%7C300x600%7C160x600&scp=pos%3Dbox_1%26lid%3D4372559252&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DHaymarket%2520Media%26postID%3D94006%26env%3Dlive%26sid%3DAllergy_and_Immunology_Information_Center%252CNews%26styleid%3D%26cat%3DAllergy_%2526amp%253B_Immunology%26atype%3DHealthday%26block%3DCA_Abilify_Maintena_2019%252CCA_Symtuza_2019%252CHMN_Rexulti_2019%252CMPR_JanssenDermatology_2019%252CTest%26isnht%3Dfalse%26browser%3DChrome%252074%26amid%3D6b84c5dc012a68d3e1bb886bfca683bfa0a3abec27a316170eac1e947c5c7fac%26spr%3D448%26ssp%3D%26cpn%3Dobgyn_md%252Celagolix_august2018%252Cobgyn_all%252Charvonitbg%252Cverzenio122018%252Cxxxx%252CPVC2019127035%252Csaxendaunbranded_feb2019%252Cintrarosa_feb2019%26subid%3D0%26usrc%3Dhaymarket%26eid%3D57cba5946efbce1c33a53f2b26ef549736a7058933221787043724da633564e9%26LyticsSegments%3Dga_med_nomycme%252Cga_med_nht_false%252Cmycme_rheum_survey_audience%252C3_day_visitors_neuro_ca_empr%252Cblackfriday_notunknown%252Cactivity_5126_audience%252Cmycme_endofyearsale_noanonymous_nosdc%252Caudience_for_mlk_sale%252Cnot_unknown_5770%252Cmycme_activity_5762%252Cactivity_5772_mycme_no_unknown_no_pulm%252Cddw_opened_to_all%252Call%252Csmt_new%252Cly_reporting_from_email%252Cly_reporting_has_visited_web%252Cly_reporting_multi_session_visitor%252Cly_reporting_last_visit_within_day%252Cly_reporting_last_visit_within_week%252Cly_reporting_last_visit_within_month%252Cly_reporting_last_visit_within_3_months%252Cly_known_email%252Cly_repeat_visitor%252Cly_international_visitor%252Cly_uses_desktop%252Cly_from_email%252Cknown%252Csite_known_ca%252Cce_salary_survey_promo_on_ca%252Call_time_visitors%252Cmycme_allergy_all_except_4797_completes%252Cmycme_hiv_all_except_4670_completes%252Cmycme_internal_med_all_except_4670_completes%252Cmycme_allergy_all_except_4744_completes%252Cmycme_psychiatry_all_except_4812_completes%252Cmycme_cardiology_all_except_cardiology_pas%252Cmycme_dermatology_all_except_4831_completes%252Cmycme_pediatrics_all_except_4354_completes%252Cmycme_acc_next_activity_promo_no_4523%252Cmycme_acc_next_activity_promo_no_4524%252Cmycme_acc_next_activity_promo_no_4525%252Cmycme_acc_next_activity_promo_no_4526%252Cmycme_acc_next_activity_promo_no_4593%252Cmycme_acc_next_activity_promo_no_4595%252Cmycme_acc_next_activity_promo_no_4710%252Cmycme_acc_next_activity_promo_no_4804%252Cmycme_acc_next_activity_promo_no_4834%252Cmycme_acc_next_activity_promo_no_4800%252Cmycme_acc_next_activity_promo_no_4792%252Cmycme_acc_next_activity_promo_no_4511%252Cmycme_acc_next_activity_promo_no_4529%252Cmycme_acc_next_activity_promo_no_4558%252Cmycme_acc_next_activity_promo_no_4634%252Cmycme_impact_next_activity_promo_no_4740%252Cmycme_impact_next_activity_promo_no_4757%252Cmycme_impact_next_activity_promo_no_4842%252Cmycme_impact_next_activity_promo_no_4816%252Cmycme_impact_next_activity_promo_no_4897%252Cmycme_impact_next_activity_promo_no_4727%252Cmycme_impact_next_activity_promo_no_4755%252Cmycme_impact_next_activity_promo_no_4791%252Cmycme_impact_next_activity_promo_no_47911%252Cmycme_impact_next_activity_promo_no_4826%252Cmycme_impact_next_activity_promo_no_4815%252Cce_excluding_mpr_print_subscribers%252Cce_excluding_ca_print_subscribers%252Cga_med_known%252Cmycme_homepage_ibs_town_wall_%252Cmycme_ddw_nash%252Cemailops060619%252Cmycme_activity_5841_2%252Cmycme_pediatrics_activity_5591&cookie=ID%3D614ed1437d8147f5%3AT%3D1568941784%3AS%3DALNI_MYPGKvGCVYQXF5NJ7iDQhpczIcS6A&cookie_enabled=1&bc=31&abxe=1&lmt=1568941785&dt=1568941785418&dlt=1568941782685&idt=647&frm=20&biw=1585&bih=1200&oid=3&adx=1053&ady=282&adk=2098156797&uci=3&ifi=3&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&dssz=82&icsg=152282377224192&mso=67108864&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=300x250&msz=300x250&psts=CioIocioP-gB-q_CjoMEggIQsbmAD4GY8iH5mPIh0dPPNNECBvd4dQ-tf8s%2CCisIlOv_pBDoAcCqq-6CBIICELG5gA-BmPIh-ZjyIdHTzzTRAhpZQBa3Gvbo&ga_vid=719138576.1568941783&ga_sid=1568941784&ga_hid=1445100269&fws=4&ohw=1585
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019091201.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.206.2 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s20-in-f2.1e100.net
Software
cafe /
Resource Hash
c798c8527cb52904fe798f608296d127e3e6e76620b371d4e9cdf647c65f0a1d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:45 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
5938
x-xss-protection
0
google-lineitem-id
4372559252
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138207217638
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.clinicaladvisor.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
truncated
/ Frame DD1D
214 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
8b24663ca06e22d181f353b89e51fda26a12687f8b099e22d28c3b7f8875b790

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
error_handler.js
tpc.googlesyndication.com/pagead/js/r20190918/r20110914/client/ Frame 5571
7 KB
3 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20190918/r20110914/client/error_handler.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091201.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:814::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
1b59bd0e492e82d006ecbdd2eca4c5f6a12af900e1f02edf66f05684c54882ff
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Wed, 18 Sep 2019 14:11:03 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
125922
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
3292
x-xss-protection
0
server
cafe
etag
7324492156235402329
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Wed, 02 Oct 2019 14:11:03 GMT
6893177778910800556
tpc.googlesyndication.com/simgad/ Frame 5571
173 KB
173 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/6893177778910800556
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091201.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:814::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
4d3730fdf6780af280eec623618f3e3ae26301b2e88482dc2c7bbcc9dd61320a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 03 Sep 2019 08:14:54 GMT
x-content-type-options
nosniff
age
1443291
x-dns-prefetch-control
off
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
176987
x-xss-protection
0
last-modified
Thu, 27 Jul 2017 15:12:25 GMT
server
sffe
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Wed, 02 Sep 2020 08:14:54 GMT
window_focus.js
tpc.googlesyndication.com/pagead/js/r20190918/r20110914/client/ Frame 5571
2 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20190918/r20110914/client/window_focus.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091201.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:814::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
d31b12baad65082a7d404da9971cc9fed871e35f29a5893f815f468f1050491f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Wed, 18 Sep 2019 14:11:02 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
125923
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
1044
x-xss-protection
0
server
cafe
etag
16885093947315342629
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Wed, 02 Oct 2019 14:11:02 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame 5571
78 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091201.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:818::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
96d487a0c7dd457eb22a400e8861a2edc90596164a67684fbe4715713e9fad7d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 01:09:45 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1568805556061895"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
29649
x-xss-protection
0
expires
Fri, 20 Sep 2019 01:09:45 GMT
init-132dn9au2z77uqg0m5w.js
api.b2c.com/api/ Frame 5571
13 KB
5 KB
Script
General
Full URL
https://api.b2c.com/api/init-132dn9au2z77uqg0m5w.js?AdUnitID_TopLevel=71076865&AdUnitID=110356945&AdvertiserID=21701905&OrderID=325626025&LineItemID=4372559252&CreativeID=138207217638&CPN=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&sid=Allergy_and_Immunology_Information_Center,News
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091201.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5802:b76e:7a35:805d:7afc Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
547b53093872274a5044a4dabd41cbaa469184b13dae9f7e85af502b97e412fe

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:45 GMT
content-encoding
gzip
server
openresty
content-type
text/javascript
status
200
cache-control
no-cache, no-store, must-revalidate
expires
-1
view
securepubads.g.doubleclick.net/pcs/ Frame 5571
0
277 B
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvjp4Ho6O1UOILKOPN52MDXPVAv-ZS8AT9U-ccbgS7s7mN6DE84cNXrmjK44Xqg4ncug1uiQjbsogZY0N919UjwH4bxsFXuIxZU25h0m_8lOki67JOxboynflUn2xepYcGKvWXK2vgDiHiXo3Gy2tfimw8fSfh0w2BAnbxikCdw-_2seLsUjW09H5aS9JspCGguRS7SdhxagYdKBh-gDqZO8r1PgwyKEXyVDX-teFt37rLmrZaU1VSdrMLsg8DWDU6XH0E6QTQRZf5fDG25cwy-Njx0_NvVj1V22phM7rmVjSOGquitffQDogUUkRgBPvjE3ntcdwsPSctJjNqVpw&sai=AMfl-YRwJovseDP-MuLnYxWQhG5JOL9_g_ifLn3qHRTUin8B8pPsZ0A_n9RX-5gzJbiYAHnGsoi0X91kLwAz75SH0J5OfHqGd6OtFuHbqG9r&sig=Cg0ArKJSzA5ZJBlL1d9fEAE&adurl=
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.206.2 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s20-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 20 Sep 2019 01:09:45 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
0
x-xss-protection
0
expires
Fri, 20 Sep 2019 01:09:45 GMT
truncated
/ Frame 5571
217 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
7253f87035b379b9f951c06fa5f11277786deb1e43127e6e79fb3450bf95c578

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
ad.gif
api-34-223-224-174.b2c.com/api/ Frame DD1D
43 B
233 B
Image
General
Full URL
https://api-34-223-224-174.b2c.com/api/ad.gif
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:9d1:9f29:a078:e210 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 20 Sep 2019 01:09:46 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
/
adtrackapi.haymarketmedia.com/adverttracking/
2 B
366 B
XHR
General
Full URL
https://adtrackapi.haymarketmedia.com/adverttracking/
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2057:600:16:bc48:4dc0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-type
application/json

Response headers

date
Fri, 20 Sep 2019 01:09:46 GMT
via
1.1 d5fb859c39a16d7f218b4c7fb1528ad6.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA6-C1
x-amzn-requestid
5ec00eb9-3cb9-4e1d-bdda-5fda4acffb62
status
200
x-cache
Miss from cloudfront
content-type
application/json
access-control-allow-origin
*
x-amzn-trace-id
Root=1-5d8426d9-6638896ef259542517ea007b;Sampled=0
x-amz-apigw-id
ASsCEGWxIAMF60Q=
content-length
2
x-amz-cf-id
lLPg8Tsz094PpZnAOOwgnw_Ht0qUKXZK8hXvxAusYXdn9kTGb7aAsw==
ad.gif
api-54-218-77-7.b2c.com/api/ Frame 5571
43 B
233 B
Image
General
Full URL
https://api-54-218-77-7.b2c.com/api/ad.gif
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:991d:cfef:e3e6:cc5c Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 20 Sep 2019 01:09:46 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
/
adtrackapi.haymarketmedia.com/adverttracking/
2 B
366 B
XHR
General
Full URL
https://adtrackapi.haymarketmedia.com/adverttracking/
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2057:600:16:bc48:4dc0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-type
application/json

Response headers

date
Fri, 20 Sep 2019 01:09:46 GMT
via
1.1 d5fb859c39a16d7f218b4c7fb1528ad6.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA6-C1
x-amzn-requestid
acf8dfc6-e74a-4eec-886d-e538e35091a7
status
200
x-cache
Miss from cloudfront
content-type
application/json
access-control-allow-origin
*
x-amzn-trace-id
Root=1-5d8426da-e1701c36237345e854373134;Sampled=0
x-amz-apigw-id
ASsCHFmzoAMFQhA=
content-length
2
x-amz-cf-id
eAFt1wUZGc4RkKwkmHbiXiMQ8Oc6Q7eKeomNQM65I7P7SmYfwmPItg==
4
api-34-223-224-174.b2c.com/api/ Frame DD1D
Redirect Chain
  • https://api-34-223-224-174.b2c.com/api/x?WF72lbkw1EnkX9a3$dXJsJDAkaHR0cHM6Ly93d3cuY2xpbmljYWxhZHZpc29yLmNvbS9ob21lL3RvcGljcy9hbGxlcmd5LWFuZC1pbW11bm9sb2d5LWluZm9ybWF0aW9uLWNlbnRlci9mZGEtdG8tYXNzZXN...
  • https://api-34-223-224-174.b2c.com:444/api/4?WF72lbkw1EnkX9a3
43 B
441 B
XHR
General
Full URL
https://api-34-223-224-174.b2c.com:444/api/4?WF72lbkw1EnkX9a3
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.223.224.174 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-223-224-174.us-west-2.compute.amazonaws.com
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 20 Sep 2019 01:09:47 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
image/gif
Access-Control-Allow-Origin
null
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
43
Expires
-1

Redirect headers

Date
Fri, 20 Sep 2019 01:09:46 GMT
Server
openresty
Location
https://api-34-223-224-174.b2c.com:444/api/4?WF72lbkw1EnkX9a3
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/html
Access-Control-Allow-Origin
https://www.clinicaladvisor.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
142
4
api-54-218-77-7.b2c.com/api/ Frame 5571
Redirect Chain
  • https://api-54-218-77-7.b2c.com/api/x?K3qQnNwvX7UGcE7F$dXJsJDAkaHR0cHM6Ly93d3cuY2xpbmljYWxhZHZpc29yLmNvbS9ob21lL3RvcGljcy9hbGxlcmd5LWFuZC1pbW11bm9sb2d5LWluZm9ybWF0aW9uLWNlbnRlci9mZGEtdG8tYXNzZXNzLW...
  • https://api-54-218-77-7.b2c.com:444/api/4?K3qQnNwvX7UGcE7F
43 B
441 B
XHR
General
Full URL
https://api-54-218-77-7.b2c.com:444/api/4?K3qQnNwvX7UGcE7F
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.218.77.7 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-54-218-77-7.us-west-2.compute.amazonaws.com
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 20 Sep 2019 01:09:47 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
image/gif
Access-Control-Allow-Origin
null
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
43
Expires
-1

Redirect headers

Date
Fri, 20 Sep 2019 01:09:46 GMT
Server
openresty
Location
https://api-54-218-77-7.b2c.com:444/api/4?K3qQnNwvX7UGcE7F
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/html
Access-Control-Allow-Origin
https://www.clinicaladvisor.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
142
x
api-34-223-224-174.b2c.com/api/ Frame DD1D
0
393 B
Other
General
Full URL
https://api-34-223-224-174.b2c.com/api/x?WF72lbkw1EnkX9a3$YWRibG9jayQ1MzUkMA
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:9d1:9f29:a078:e210 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Pragma
no-cache
Date
Fri, 20 Sep 2019 01:09:46 GMT
Server
openresty
Transfer-Encoding
chunked
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
https://www.clinicaladvisor.com
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Expires
-1
x
api-54-218-77-7.b2c.com/api/ Frame 5571
0
393 B
Other
General
Full URL
https://api-54-218-77-7.b2c.com/api/x?K3qQnNwvX7UGcE7F$YWRibG9jayQ1MzckMA
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:991d:cfef:e3e6:cc5c Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Pragma
no-cache
Date
Fri, 20 Sep 2019 01:09:46 GMT
Server
openresty
Transfer-Encoding
chunked
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
https://www.clinicaladvisor.com
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Expires
-1
activeview
pagead2.googlesyndication.com/pcs/ Frame DD1D
42 B
110 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjssASTknYXBrF0CJyClUM307g1uKX7hbFuLSebXjOrrd3Q6nM5FoLezbN1AjOKV-F1TzppIpKXev6q8NTzBc8hA0iA7lTedWm5tUee3Zhuc&sig=Cg0ArKJSzF_RXankDPkNEAE&adk=3943181460&tt=-1&bs=1585%2C1200&mtos=1063,1063,1063,1063,1063&tos=1063,0,0,0,0&p=102,212,192,940&mcvt=1063&rs=3&ht=0&tfs=910&tls=1973&mc=1&lte=1&bas=0&bac=0&met=0&avms=nio&niot_obs=876&niot_cbk=890&md=2&lm=2&rst=1568941785412&rpt=24&isd=0&msd=0&oseid=3&xdi=0&ps=1585%2C3023&ss=1600%2C1200&pt=-1&bin=1&deb=1-1-3-14-19-10-47-18-0-0-0&tvt=1968&r=v&id=osdim&vs=4&za&uc=11&upc=1&tgt=DIV&cl=1&cec=1&clc=1&cac=1&cd=728x90&itpl=3&v=20190918
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:818::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:46 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
status
200
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
activeview
pagead2.googlesyndication.com/pcs/ Frame 5571
42 B
110 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjsuSOd3EI77ohLeL4pJQWJLai0V-ds-0uwirtkp4V6NFpheEEAWQuzL_YO36wlTjfDscwlhNRIQumYtFjZlzpuNITYjiCeiBRVXMQuHSGpQ&sig=Cg0ArKJSzF4Vi1cjPOg_EAE&adk=2098156797&tt=-1&bs=1585%2C1200&mtos=1064,1064,1064,1064,1064&tos=1064,0,0,0,0&p=282,1053,882,1353&gcm=1&lcs=1&mcvt=1064&rs=3&ht=0&tfs=1118&tls=2182&mc=1&lte=1&bas=0&bac=0&met=0&avms=nio&niot_obs=983&niot_cbk=991&md=2&lm=2&rst=1568941785518&rpt=37&isd=0&msd=0&oseid=3&xdi=0&ps=1585%2C3023&ss=1600%2C1200&pt=-1&bin=1&deb=1-1-3-18-21-10-53-20-0-0-0&tvt=2177&r=v&id=osdim&vs=4&za&uc=12&upc=1&tgt=DIV&cl=1&cec=1&clc=1&cac=1&cd=300x600&itpl=3&v=20190918
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:818::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:46 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
status
200
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
Cookie set rt=ifr
bcp.crwdcntrl.net/5/ct=y/c=14419/rand=851428171/pv=y/ver=1.4/int=%23OpR%2396858%23Total%20Site%20Traffic%20%3A%20www.clinicaladvisor.com/int=%23OpR%2396859%23www.clinicaladvisor.com%20%3A%20Site%20... Frame D696
Redirect Chain
  • https://bcp.crwdcntrl.net/5/c=14419/rand=851428171/pv=y/ver=1.4/int=%23OpR%2396858%23Total%20Site%20Traffic%20%3A%20www.clinicaladvisor.com/int=%23OpR%2396859%23www.clinicaladvisor.com%20%3A%20Site...
  • https://bcp.crwdcntrl.net/5/ct=y/c=14419/rand=851428171/pv=y/ver=1.4/int=%23OpR%2396858%23Total%20Site%20Traffic%20%3A%20www.clinicaladvisor.com/int=%23OpR%2396859%23www.clinicaladvisor.com%20%3A%2...
0
0
Document
General
Full URL
https://bcp.crwdcntrl.net/5/ct=y/c=14419/rand=851428171/pv=y/ver=1.4/int=%23OpR%2396858%23Total%20Site%20Traffic%20%3A%20www.clinicaladvisor.com/int=%23OpR%2396859%23www.clinicaladvisor.com%20%3A%20Site%20Section%20%3A%20home/int=%23OpR%2396860%23www.clinicaladvisor.com%20%3A%20Site%20Section%20%3A%20home%20%20%3A%20topics/int=%23OpR%2397492%23www.clinicaladvisor.com%20%3A%20Site%20Section%20%3A%20home%20%3A%20topics%20%3A%20allergy-and-immunology-information-center/int=%23OpR%2397493%23www.clinicaladvisor.com%20%3A%20Site%20Section%20%3A%20home%20%3A%20topics%20%3A%20allergy-and-immunology-information-center%20%3A%20fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/act=%23OpR%2397530%23www.clinicaladvisor.com%20%3A%20Sign%20Up%20for%20Free%20E-News%20Letter/med=%23OpR%2397539%23Article%20Tags%20%3A%20Allergy%20%26%20Immunology/rb=%7B%22url%22%3A%22https%3A%2F%2Fwww.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181%22%7D/rt=ifr
Requested by
Host: tags.crwdcntrl.net
URL: https://tags.crwdcntrl.net/c/14419/cc.js?ver=1.4&ns=_cc14419
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.250.208.218 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-250-208-218.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash

Request headers

Host
bcp.crwdcntrl.net
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
Sec-Fetch-Site
cross-site
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Accept-Encoding
gzip, deflate, br
Cookie
_cc_cc=ctst
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181

Response headers

Access-Control-Allow-Origin
*
Cache-Control
no-cache
Content-Encoding
gzip
Content-Type
text/html;charset=UTF-8
Date
Fri, 20 Sep 2019 01:09:49 GMT
Expires
0
P3P
CP=NOI DSP COR NID PSAa PSDa OUR UNI COM NAV
Pragma
no-cache
Set-Cookie
_cc_dc=1;Path=/;Domain=crwdcntrl.net;Expires=Tue, 16-Jun-2020 01:06:00 GMT;SameSite=None _cc_id=31a2d085fe5b6cb16bdbff102dc4eaab;Path=/;Domain=crwdcntrl.net;Expires=Tue, 16-Jun-2020 01:06:00 GMT;SameSite=None _cc_cc="ACZ4nGNQMDZMNEoxsDBNSzVNMktOMjRLSklKSzM0MEpJNklNTExiAILYFrW73%2F%2F%2F%2F8%2FPAANCJ0%2B1KDJeLmD4z8jIcPXYKjj76bNpcPaiaQg196ci2H9Aeq9C2H%2F3INitP3bA2RcWTYezTx5EqJl%2BQp0JYgxM4eI5LKgiD6b2MKKKfPxsiSpw%2BfkdWVSRwxjGXDr1iA1VZP%2Fyo2i6AG32csg%3D";Version=1;Path=/;Domain=crwdcntrl.net;Expires=Tue, 16-Jun-2020 01:06:00 GMT;Max-Age=23328000;SameSite=None _cc_aud="ABR4nGNgYGCIbVG7ywADzAwct0%2BBGBy3T4CpK7VAEgB3zwaZ";Version=1;Path=/;Domain=crwdcntrl.net;Expires=Tue, 16-Jun-2020 01:06:00 GMT;Max-Age=23328000;SameSite=None
Vary
Accept-Encoding
X-Server
10.45.24.123
Content-Length
586
Connection
keep-alive

Redirect headers

Cache-Control
no-cache
Date
Fri, 20 Sep 2019 01:09:49 GMT
Expires
0
Location
https://bcp.crwdcntrl.net/5/ct=y/c=14419/rand=851428171/pv=y/ver=1.4/int=%23OpR%2396858%23Total%20Site%20Traffic%20%3A%20www.clinicaladvisor.com/int=%23OpR%2396859%23www.clinicaladvisor.com%20%3A%20Site%20Section%20%3A%20home/int=%23OpR%2396860%23www.clinicaladvisor.com%20%3A%20Site%20Section%20%3A%20home%20%20%3A%20topics/int=%23OpR%2397492%23www.clinicaladvisor.com%20%3A%20Site%20Section%20%3A%20home%20%3A%20topics%20%3A%20allergy-and-immunology-information-center/int=%23OpR%2397493%23www.clinicaladvisor.com%20%3A%20Site%20Section%20%3A%20home%20%3A%20topics%20%3A%20allergy-and-immunology-information-center%20%3A%20fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/act=%23OpR%2397530%23www.clinicaladvisor.com%20%3A%20Sign%20Up%20for%20Free%20E-News%20Letter/med=%23OpR%2397539%23Article%20Tags%20%3A%20Allergy%20%26%20Immunology/rb=%7B%22url%22%3A%22https%3A%2F%2Fwww.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181%22%7D/rt=ifr
P3P
CP=NOI DSP COR NID PSAa PSDa OUR UNI COM NAV
Pragma
no-cache
Set-Cookie
_cc_cc=ctst;Path=/;Domain=crwdcntrl.net;SameSite=None
X-Server
10.45.25.126
Content-Length
0
Connection
keep-alive
cs.js
sb.scorecardresearch.com/c2/21948019/
0
400 B
Script
General
Full URL
https://sb.scorecardresearch.com/c2/21948019/cs.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-PXC3M3S
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.19.43.224 , Ascension Island, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a2-19-43-224.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 20 Sep 2019 01:09:49 GMT
Content-Encoding
gzip
Last-Modified
Fri, 08 Apr 2011 23:11:26 GMT
ETag
"d41d8cd98f00b204e9800998ecf8427e:1349196464"
Vary
Accept-Encoding
Content-Type
application/x-javascript
Cache-Control
private, no-transform, max-age=259200
Connection
keep-alive
Content-Length
20
Expires
Mon, 23 Sep 2019 01:09:49 GMT
init-121b5si20pnxjymcwdz.js
api.b2c.com/api/
12 KB
5 KB
Script
General
Full URL
https://api.b2c.com/api/init-121b5si20pnxjymcwdz.js?isNHT=false
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5802:b76e:7a35:805d:7afc Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
8c70ecadc8e1953a9618393497bc39d513650d2f22e57f0b8d987d08c90acdba

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:49 GMT
content-encoding
gzip
server
openresty
content-type
text/javascript
status
200
cache-control
no-cache, no-store, must-revalidate
expires
-1
up
insight.adsrvr.org/track/ Frame E476
0
0
Document
General
Full URL
https://insight.adsrvr.org/track/up?adv=wxli9bh&ref=https%3A%2F%2Fwww.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&upid=narppxi&upv=1.1.0
Requested by
Host: js.adsrvr.org
URL: https://js.adsrvr.org/up_loader.1.1.0.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.246.153.43 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-54-246-153-43.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash

Request headers

:method
GET
:authority
insight.adsrvr.org
:scheme
https
:path
/track/up?adv=wxli9bh&ref=https%3A%2F%2Fwww.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&upid=narppxi&upv=1.1.0
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
accept-encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181

Response headers

status
200
date
Fri, 20 Sep 2019 01:09:49 GMT
content-type
text/html
cache-control
private,no-cache, must-revalidate
pragma
no-cache
x-aspnet-version
4.0.30319
p3p
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV"
ga-audiences
www.google.de/ads/
Redirect Chain
  • https://www.google-analytics.com/r/collect?v=1&_v=j79&a=1445100269&t=event&ni=1&_s=1&dl=https%3A%2F%2Fwww.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-as...
  • https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-1290429-4&cid=719138576.1568941783&jid=1085905300&_gid=1959208939.1568941789&gjid=402992205&_v=j79&z=987241644
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-4&cid=719138576.1568941783&jid=1085905300&_v=j79&z=987241644
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-4&cid=719138576.1568941783&jid=1085905300&_v=j79&z=987241644&slf_rd=1&random=3244639344
42 B
109 B
Image
General
Full URL
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-4&cid=719138576.1568941783&jid=1085905300&_v=j79&z=987241644&slf_rd=1&random=3244639344
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81c::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:49 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, no-store, must-revalidate
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:49 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
302
content-type
text/html; charset=UTF-8
location
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-4&cid=719138576.1568941783&jid=1085905300&_v=j79&z=987241644&slf_rd=1&random=3244639344
cache-control
no-cache, no-store, must-revalidate
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
collect
www.google-analytics.com/
35 B
99 B
Image
General
Full URL
https://www.google-analytics.com/collect?v=1&_v=j79&a=1445100269&t=event&ni=1&_s=1&dl=https%3A%2F%2Fwww.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dca-update-hay-20190920%26cpn%3Dobgyn_md%2Celagolix_august2018%2Cobgyn_all%2Charvonitbg%2Cverzenio122018%2Cxxxx%2CPVC2019127035%2Csaxendaunbranded_feb2019%2Cintrarosa_feb2019%26hmSubId%3D%26hmEmail%3DZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1%26NID%3D1457423279%26email_hash%3D3885467ebb475d4f7de802335f394fcc%26dl%3D0%26mpweb%3D1323-68670-2332181&ul=en-us&de=UTF-8&dt=FDA%20to%20Assess%20First%20Drug%20Meant%20to%20Prevent%20Peanut%20Allergy%20-%20Clinical%20Advisor&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&ec=Scroll%20Depth&ea=%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-assess-first-drug-meant-to-prevent-peanut-allergy%2F&el=25%25&ev=25&_u=aGjAAAAjQ~&jid=&gjid=&cid=719138576.1568941783&tid=UA-1290429-4&_gid=1959208939.1568941789&gtm=2wg9b0PXC3M3S&z=1111699622
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 23 Aug 2019 19:19:23 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
age
2353826
status
200
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
35
expires
Mon, 01 Jan 1990 00:00:00 GMT
ad.gif
api-54-191-43-35.b2c.com/api/
43 B
233 B
Image
General
Full URL
https://api-54-191-43-35.b2c.com/api/ad.gif
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:5263:8a5d:ba92:bc6f Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 20 Sep 2019 01:09:49 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
4
api-54-191-43-35.b2c.com/api/
Redirect Chain
  • https://api-54-191-43-35.b2c.com/api/x?6d9jARngt8b43j1F$dXJsJDAkaHR0cHM6Ly93d3cuY2xpbmljYWxhZHZpc29yLmNvbS9ob21lL3RvcGljcy9hbGxlcmd5LWFuZC1pbW11bm9sb2d5LWluZm9ybWF0aW9uLWNlbnRlci9mZGEtdG8tYXNzZXNzL...
  • https://api-54-191-43-35.b2c.com:444/api/4?6d9jARngt8b43j1F
43 B
441 B
XHR
General
Full URL
https://api-54-191-43-35.b2c.com:444/api/4?6d9jARngt8b43j1F
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.191.43.35 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-54-191-43-35.us-west-2.compute.amazonaws.com
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 20 Sep 2019 01:09:50 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
image/gif
Access-Control-Allow-Origin
null
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
43
Expires
-1

Redirect headers

Date
Fri, 20 Sep 2019 01:09:50 GMT
Server
openresty
Location
https://api-54-191-43-35.b2c.com:444/api/4?6d9jARngt8b43j1F
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/html
Access-Control-Allow-Origin
https://www.clinicaladvisor.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
142
x
api-54-191-43-35.b2c.com/api/
0
393 B
Other
General
Full URL
https://api-54-191-43-35.b2c.com/api/x?6d9jARngt8b43j1F$YWRibG9jayQ1NDEkMA
Requested by
Host: www.clinicaladvisor.com
URL: https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:5263:8a5d:ba92:bc6f Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Pragma
no-cache
Date
Fri, 20 Sep 2019 01:09:50 GMT
Server
openresty
Transfer-Encoding
chunked
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
https://www.clinicaladvisor.com
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Expires
-1
ga-audiences
www.google.de/ads/
Redirect Chain
  • https://www.google-analytics.com/r/collect?v=1&_v=j79&a=1445100269&t=event&ni=0&_s=1&dl=https%3A%2F%2Fwww.clinicaladvisor.com%2Fhome%2Ftopics%2Fallergy-and-immunology-information-center%2Ffda-to-as...
  • https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-1290429-4&cid=719138576.1568941783&jid=494651994&_gid=1891035648.1568941798&gjid=1453491562&_v=j79&z=233739712
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-4&cid=719138576.1568941783&jid=494651994&_v=j79&z=233739712
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-4&cid=719138576.1568941783&jid=494651994&_v=j79&z=233739712&slf_rd=1&random=1351949555
42 B
109 B
Image
General
Full URL
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-4&cid=719138576.1568941783&jid=494651994&_v=j79&z=233739712&slf_rd=1&random=1351949555
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81c::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:57 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, no-store, must-revalidate
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Fri, 20 Sep 2019 01:09:57 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
302
content-type
text/html; charset=UTF-8
location
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-4&cid=719138576.1568941783&jid=494651994&_v=j79&z=233739712&slf_rd=1&random=1351949555
cache-control
no-cache, no-store, must-revalidate
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
imsync.ashx
ml314.com/
17 B
427 B
Script
General
Full URL
https://ml314.com/imsync.ashx?pi=5978151499129049387&data=eyJwaCI6MjU1NCwid2giOjEyMDAsInRicyI6MCwiZHQiOjE1LCJwaWQiOiIxNTY4OTQxNzgzNDI1XzAwMHR6bjQ4OSIsInNkIjoxMjAwfQ%3D%3D
Requested by
Host: ml314.com
URL: https://ml314.com/tag.aspx?2082019
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.252.62.73 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-252-62-73.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
62ce950ad0d7f664b316b4253bbc993bf0bf8310970f64b150fda6f1fa59dfea

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.clinicaladvisor.com/home/topics/allergy-and-immunology-information-center/fda-to-assess-first-drug-meant-to-prevent-peanut-allergy/?utm_source=newsletter&utm_medium=email&utm_campaign=ca-update-hay-20190920&cpn=obgyn_md,elagolix_august2018,obgyn_all,harvonitbg,verzenio122018,xxxx,PVC2019127035,saxendaunbranded_feb2019,intrarosa_feb2019&hmSubId=&hmEmail=ZsiQO9eqGWO8eOCba-Xg-XHSa5YjROG0gqbP1HaB5lo1&NID=1457423279&email_hash=3885467ebb475d4f7de802335f394fcc&dl=0&mpweb=1323-68670-2332181
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 20 Sep 2019 01:09:57 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
text/html; charset=utf-8
Cache-Control
private
Connection
keep-alive
Content-Length
135

Verdicts & Comments Add Verdict or Comment

202 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| onformdata object| onpointerrawupdate number| pamEnabled object| hmAds object| dataLayer object| $ function| jQuery function| cookie object| _cc14419 object| LOTCC object| Digest string| NativeAIObject function| nativeAI function| UtilityMove object| core object| __core-js_shared__ object| global object| System function| asap function| Observable function| setImmediate function| clearImmediate object| regeneratorRuntime boolean| _babelPolyfill object| googletag object| ggeac object| closure_memoize_cache_ object| googleToken object| googleIMState object| google_js_reporting_queue function| processGoogleToken object| google_tag_manager string| GoogleAnalyticsObject function| ga string| adTrackProxyPath string| advertTrackingApiUrl boolean| trackImpressionsViewable object| clickedAd boolean| isOverIFrame object| dfpRequests function| waitFor function| DataLayerExist function| AdSlotsRegistered function| TrackPassbackImpression function| TrackImpression function| TrackImpressionViewable function| AdClick function| checkDuplicateImpression function| callApi function| AmazonWebService function| createAdTrackingMessage function| getAJAXObject function| trackAdvert function| xdTrackAdvert function| getRenderedAd function| EventType function| getPageDetails function| getPageName function| getSection1 function| getPageType function| getDevice function| getValueFromTargets function| getPageTypeId function| getBrowser function| getUser function| getDfpTimestamp function| getCookies function| getTimeStamp function| ProcessMouseOut function| ProcessMouseOver function| processIFrameClick function| getDfpUrlFor function| getDfpUrls function| logAdvertRequested object| dataLayerService function| hmHeaderLoginState object| dfpAdSlots object| mapping object| adSlotsConfig object| allowedSlots string| hmHomeUrl string| hmAccountUrl object| hmRegisteredAds boolean| hmAdsLazyload number| hmAdsActiveRefresh boolean| hmAdsCommentsHouse boolean| hmDmdAimEnabled boolean| hmProclivityEnabled boolean| hmAdsActiveRefreshAll boolean| hmAdsBoxReposition boolean| hmAdsLytics object| adSlots number| adDebug object| hmProclivity string| cpn object| haymarketCustomEvents object| google_tag_data object| gaplugins object| gaGlobal object| gaData object| CE2 string| __INDIVIDUAL_ONE_VERSION_ev-store_ENFORCE_SINGLETON undefined| __INDIVIDUAL_ONE_VERSION_ev-store function| fbq function| _fbq function| retry function| isIE10OrLater function| detectPrivateMode string| redirect undefined| google_measure_js_timing boolean| google_noFetch number| __google_ad_urls_id object| countVars function| maropostInitTracking string| name_funnel function| _132310 string| name_funnel1 function| _13231 object| data object| ids string| disqus_shortname object| hm_localize object| hm_gated object| date function| isStorageSupported function| truncateItem function| storeData function| removeData function| retrieveData function| readStorage function| getExpiration object| google_optimize object| ns_ object| TenUp object| liosetup object| jstag object| hmAuthNoncePromise function| disqus_config object| hmRegisterPrompt function| hmSetLyticsData object| adblockDetector object| pageVars object| wp function| hmOpenRegisterPrompt function| webpackJsonp object| AIM object| _ml function| __jstag_onload undefined| initObj string| ly_cid object| nativeAIWebpackJsonp function| ns360 object| News360 object| NativeAI string| set_domain function| domain_name function| deleteMaroClickScriptTag function| maroRecordClick function| anchor_event_add function| maroRecordTime function| maroTrackInit object| lio function| ttd_dom_ready function| TTDUniversalPixelApi object| _0x21b7 function| _0x5b38 object| optimizely object| pathfora function| HMIRegistration object| ssoLogin object| ssoRegister number| google_unique_id object| google_reactive_ads_global_state function| Goog_AdSense_getAdAdapterInstance function| Goog_AdSense_OsdAdapter object| __google_ad_urls object| ampInaboxIframes object| ampInaboxPendingMessages boolean| google_osd_loaded boolean| google_onload_fired function| Goog_Osd_UnloadAdBlock function| Goog_Osd_UpdateElementToMeasure function| google_osd_amcb object| DISQUSWIDGETS undefined| disqus_domain object| gtm string| string1 string| string2 string| string3 string| string4 string| string5 string| string6 string| string7 string| string8 string| string9 string| string10 number| lySegmentCounter string| result string| key function| checkForCPNSegments function| logit function| __$PP

0 Cookies

82 Console Messages

Source Level URL
Text
console-api log URL: https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-includes/js/jquery/jquery-migrate.min.js?ver=1.4.1(Line 2)
Message:
JQMIGRATE: Migrate is installed, version 1.4.1
console-api log URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js(Line 540)
Message:
interactive
console-api log (Line 2)
Message:
DMD AIM data:{}
console-api log URL: https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1567085297(Line 1)
Message:
[ABD] start beginTest
console-api log URL: https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1567085297(Line 1)
Message:
[ABD] adding bait node to DOM
console-api log URL: https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1567085297(Line 1)
Message:
[ABD] start beginTest
console-api log URL: https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1567085297(Line 1)
Message:
[ABD] adding bait node to DOM
console-api log (Line 8)
Message:
logit -ga_med_nomycme
console-api log (Line 8)
Message:
logit -ga_med_nht_false
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_rheum_survey_audience)
console-api log (Line 6)
Message:
checkForCPNSegments(3_day_visitors_neuro_ca_empr)
console-api log (Line 6)
Message:
checkForCPNSegments(blackfriday_notunknown)
console-api log (Line 6)
Message:
checkForCPNSegments(activity_5126_audience)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_endofyearsale_noanonymous_nosdc)
console-api log (Line 6)
Message:
checkForCPNSegments(audience_for_mlk_sale)
console-api log (Line 6)
Message:
checkForCPNSegments(not_unknown_5770)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_activity_5762)
console-api log (Line 6)
Message:
checkForCPNSegments(activity_5772_mycme_no_unknown_no_pulm)
console-api log (Line 6)
Message:
checkForCPNSegments(ddw_opened_to_all)
console-api log (Line 8)
Message:
logit -all
console-api log (Line 6)
Message:
checkForCPNSegments(all)
console-api log (Line 6)
Message:
checkForCPNSegments(smt_new)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_from_email)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_has_visited_web)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_multi_session_visitor)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_last_visit_within_day)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_last_visit_within_week)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_last_visit_within_month)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_last_visit_within_3_months)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_known_email)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_repeat_visitor)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_international_visitor)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_uses_desktop)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_from_email)
console-api log (Line 6)
Message:
checkForCPNSegments(known)
console-api log (Line 6)
Message:
checkForCPNSegments(site_known_ca)
console-api log (Line 6)
Message:
checkForCPNSegments(ce_salary_survey_promo_on_ca)
console-api log (Line 6)
Message:
checkForCPNSegments(all_time_visitors)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_allergy_all_except_4797_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_hiv_all_except_4670_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_internal_med_all_except_4670_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_allergy_all_except_4744_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_psychiatry_all_except_4812_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_cardiology_all_except_cardiology_pas)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_dermatology_all_except_4831_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_pediatrics_all_except_4354_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4523)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4524)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4525)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4526)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4593)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4595)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4710)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4804)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4834)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4800)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4792)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4511)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4529)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4558)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4634)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4740)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4757)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4842)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4816)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4897)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4727)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4755)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4791)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_47911)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4826)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4815)
console-api log (Line 6)
Message:
checkForCPNSegments(ce_excluding_mpr_print_subscribers)
console-api log (Line 6)
Message:
checkForCPNSegments(ce_excluding_ca_print_subscribers)
console-api log (Line 8)
Message:
logit -ga_med_known
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_homepage_ibs_town_wall_)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_ddw_nash)
console-api log (Line 6)
Message:
checkForCPNSegments(emailops060619)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_activity_5841_2)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_pediatrics_activity_5591)
console-api log (Line 5)
Message:
OK
console-api log URL: https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1567085297(Line 1)
Message:
[ABD] exiting test loop - value: false

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

accounts.haymarketmedia.com
adservice.google.com
adservice.google.de
adtrackapi.haymarketmedia.com
api-34-223-224-174.b2c.com
api-54-191-43-35.b2c.com
api-54-218-77-7.b2c.com
api.b2c.com
api.lytics.io
bcp.crwdcntrl.net
c.lytics.io
cdn.native.ai
clinicaladvisor.disqus.com
connect.facebook.net
content.maropost.com
fonts.googleapis.com
fonts.gstatic.com
idsync.rlcdn.com
in.ml314.com
insight.adsrvr.org
js.adsrvr.org
link.email.clinicaladvisor.com
media.chemotherapyadvisor.com
media.clinicaladvisor.com
media.endocrinologyadvisor.com
media.rheumatologyadvisor.com
ml314.com
mpct1.maropost.com
mt.sitomobile.com
owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com
pagead2.googlesyndication.com
pixel.mathtag.com
pixel.tapad.com
ps.eyeota.net
s3.amazonaws.com
sb.scorecardresearch.com
script.crazyegg.com
securepubads.g.doubleclick.net
sp.sitomobile.com
stats.g.doubleclick.net
subapi.haymarketmedia.com
sync.crwdcntrl.net
tags.bluekai.com
tags.crwdcntrl.net
tpc.googlesyndication.com
www.clinicaladvisor.com
www.facebook.com
www.google-analytics.com
www.google.com
www.google.de
www.googletagmanager.com
www.googletagservices.com
www.medtargetsystem.com
www.oncologynurseadvisor.com
104.111.241.32
13.35.253.32
13.35.253.49
13.35.253.58
143.204.207.113
143.204.214.25
143.204.214.39
151.101.12.134
18.195.52.121
2.18.233.201
2.19.43.224
216.58.206.2
2600:1f14:e96:5800:5263:8a5d:ba92:bc6f
2600:1f14:e96:5800:991d:cfef:e3e6:cc5c
2600:1f14:e96:5800:9d1:9f29:a078:e210
2600:1f14:e96:5802:b76e:7a35:805d:7afc
2600:9000:2057:600:16:bc48:4dc0:93a1
2600:9000:20bb:7000:1b:fadc:b780:93a1
2606:4700:20::6819:5365
2606:4700::6813:9408
2a00:1450:4001:809::200a
2a00:1450:4001:814::2001
2a00:1450:4001:817::2002
2a00:1450:4001:818::2002
2a00:1450:4001:81c::2003
2a00:1450:4001:81f::2004
2a00:1450:4001:820::2008
2a00:1450:4001:825::2003
2a00:1450:4001:825::200e
2a00:1450:400c:c08::9d
2a03:2880:f02d:12:face:b00c:0:3
2a03:2880:f12d:83:face:b00c:0:25de
3.211.28.224
3.94.35.144
34.223.224.174
34.233.109.111
34.250.208.218
34.252.62.73
34.252.7.165
35.172.78.117
35.174.96.0
35.190.72.21
35.227.192.113
35.227.248.159
35.238.92.4
52.1.219.33
52.216.177.205
54.156.255.160
54.191.43.35
54.210.29.109
54.218.77.7
54.246.153.43
93.184.220.113
94.31.29.64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